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ABSTRACT 
 
Heart failure (HF) has become a major health problem with its high prevalence, poor 
clinical outcomes, and large health-care costs. Compared with medical intervention, the 
prevention of HF through lifestyle approaches is free of side effect. Therefore, the prevention 
of HF through lifestyle approaches is of special interest. In this project, we aim to investigate 
1) the association of different levels of occupational, commuting and leisure-time physical 
activity with HF risk; 2) the association of coffee consumption with HF risk; 3) the role of 
lifestyle factors in explaining the risk of HF; and 4) the association between antihypertensive 
drug treatment and HF risk with the association between engaging in a healthy lifestyle and 
HF risk. 
We conducted prospective studies among Finnish men and women who were 25 to 74 
years of age and free of HF at baseline. Cox proportional hazards regression models were 
used to estimate the associations of interest. Partial population attributable risk was 
calculated to estimate the proportion of new HF cases occurring in this population that 
hypothetically could have been prevented if all subjects had certain health lifestyle factors.  
Our study results showed that 1) moderate and high levels of occupational or 
leisure-time physical activity are associated with a reduced risk of HF in both sexes; A 
simultaneous engagement in two or three types of physical activity showed a slightly 
stronger protective effect than participation in only one type of physical activity; 2) coffee 
consumption does not increase the risk of HF in Finnish men and women; In women, we 
observed an inverse association between low-to-moderate coffee consumption and the risk of 
HF; 3) maintaining a body mass index ≤25, consuming vegetable ≥3 times a week, 
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abstaining from smoking and engaging in moderate or high level of physical activity were 
individually and jointly associated with a decreased risk of HF among both men and women; 
The relationship between the number of healthy lifestyle factors one engaged in and HF risk 
was dose-response; and 4) HF risk was lower in hypertensive patients who engaged in a 
healthy lifestyle but higher in hypertensive people using antihypertensive drug treatment.
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CHAPTER 1. OVERVIEW 
1.1 Introduction 
Heart Failure (HF) has emerged as a major and growing health problem both in the 
developed and developing regions of the world.(Schocken et al., 2008a) Although use of 
medication has reduced re-hospitalization rates and mortality from HF,(Lee et al., 2004) it 
remains the leading cause of hospitalization for older people in the United States.(Kozak et 
al., 2006) Mortality among HF patients remains substantial. About one quarter of patients 
died within one year of diagnosis and half died within five years of diagnosis.(Levy et al., 
2002; Roger et al., 2004) Therefore, the prevention of HF through lifestyle approaches is of 
special interest. The association of lifestyle factors with HF risk will be evaluated in the 
studies described in this application using the FINRISK Study, conducted in Finland. 
The FINRISK Study is one of the largest prospective epidemiological studies of chronic 
disease risk factors in the world. The total sample consists of 62,013 randomly selected 
individuals (30,031 men and 31,982 women) aged 25-74 years. Baseline data collections 
include medical history, socio-economic factors, lifestyle factors, and the direct 
measurements of height, weight, blood pressure, and serum total cholesterol. The follow-up 
is virtually complete through the nationwide register linkage. During a mean follow-up of 
18.4 years, 1992 men and 1771 women developed incident HF. Thus, this is one of the 
largest prospective studies of HF in the world. The existing data and data which will be 
generated during further follow-up of this cohort provide a unique opportunity to identify 
potential preventive strategies for HF. 
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Specifically, we provide detailed evaluations of the following research questions in this 
dissertation: 
Research Questions 
1. Does physical activity during occupation, commuting, and/or leisure time decrease 
HF risk? 
2. Does coffee consumption influence the risk of HF? 
3. What are the joint effects of lifestyle factors (physical activity, alcohol consumption, 
coffee consumption, smoking, and obesity) on the risk of HF? 
4. Whether there are differences in HF risk among hypertensive men and women using 
antihypertensive drug treatment at baseline versus those engaging in a healthy 
lifestyle at baseline? 
Hypotheses 
1. Physical activity during occupation, commuting, and/or leisure time decrease HF 
risk. 
2. Coffee consumption influences HF risk. 
3. Lifestyle factors (physical activity, alcohol consumption, coffee consumption, 
smoking, and obesity) influences HF risk. 
4. Differences exist in HF risk among hypertensive men and women using 
antihypertensive drug treatment at baseline versus those engaging in a healthy 
lifestyle at baseline 
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Justification 
According to the World Health Organization (WHO), the knowledge about the 
epidemiology, risk factors, prognosis, treatment, and prevention of coronary heart disease 
(CHD) and stroke has been investigated more systematically than that of HF because only a 
few population-based epidemiologic studies are available for HF.(World Health 
Organization) Data from a few population-based epidemiologic studies in the US and Europe 
have provided evidence that lifestyle factors play an important role in the etiology of HF.(He 
et al., 2001; Kannel et al., 1999; Schocken et al., 2008a) Thus, the prevention of HF through 
lifestyle approaches is possible. In order to determine interventions that would prevent or 
delay the onset of HF, identification of modifiable risk factors for HF is indispensable 
because these risk factors could then be used as targets for intervention. Therefore, 
independent confirmation and further exploration of lifestyle factors with the risk of HF in 
well-designed large prospective studies will provide crucial information for us to gain a 
better understanding of the complex lifestyle-HF relationships. 
The present study, which is part of the FINRISK study, utilized a prospective cohort 
design. The subjects involved in this study were general population of Finland. The study 
sample was nationally representative. The present study would provide important information 
for understanding the causes and prevention strategies of HF. 
Limitations 
1. Study cohorts represented random samples of Finnish men and women. However, 
results of the present study may not be able to generalize to other populations. 
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2. Even though we gathered data on several potential confounders such as age, 
education, blood pressure, total cholesterol etc., residual confounding due to 
measurement error in the assessment of confounding factors, or some unmeasured 
dietary factors were not determined thus, cannot be excluded.  
3. All exposure and covariate information was measured at baseline surveys prior to HF 
diagnoses. We have no data on possible changes in these factors during the follow-up. 
The misclassification of the levels of these factors during the follow-up is most 
probably not systematically related to the outcome, but may weaken the observed 
association. 
1.2 Review of literature 
Epidemiology of HF 
HF has emerged as a worldwide epidemic and is one of the leading causes of morbidity 
and mortality for old people in the US and other Western countries.(He et al., 2001; 
Nieminen and Harjola, 2005) According to the estimation of American Heart Association 
(AHA), 550,000 new cases occur each year, and more than 5 million Americans have 
HF.(Schocken et al., 2008a) According to the estimation of the European Society of 
Cardiology (ESC), 10 million people have HF in the Europe, and HF patients accounts for 
0.4% to 2% of the general European population.(Nieminen and Harjola, 2005) In addition, 
HF has put a heavy economic burden on the society. An estimated of > $33 billion was spent 
on HF in 2007 according to AHA.(Schocken et al., 2008a) 
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Overweight/obesity, physical activity and HF
1
 
The epidemic of unhealthy lifestyle habits including, overweight/obesity and sedentary 
lifestyle has serious public health and economic consequences. Obesity, which may be 
caused by unhealthy diet and/or physical inactivity, has long been regarded as a major public 
health problem in the US(Allison et al., 1999). The data from a community-based study 
conducted among subjects aged 65 years and over living in New Haven has shown that 
obesity, as assessed by body mass index (BMI: calculated as weight [kilogram] divided by 
height squared [square meter]) ≥28, is a predictor for HF risk.(Chen et al., 1999) This finding 
has been confirmed by many other studies.(Bahrami et al., 2008; He et al., 2001; Hu et al.; 
Ingelsson et al., 2005b; Ingelsson et al., 2005c; Kenchaiah et al., 2002; Kenchaiah et al., 
2009; Levitan et al., 2009a; Loehr et al., 2009; Nicklas et al., 2006) It was not until recent 
years that scientists began to include the indexes of abdominal obesity: waist circumference 
(WC), waist-to-hip ratio (WHR: WC [centimeter] divided by hip circumference [centimeter]), 
waist-height ratio (WHtR: WC [centimeter] divided by height [centimeter]) and waist-to-thigh 
ratio (WTR: WC [centimeter] divided by thigh circumference [centimeter]) into their 
studies.(Bahrami et al., 2008; Hu et al., 2010b; Ingelsson et al., 2005c; Levitan et al., 2009a; 
Loehr et al., 2009; Nicklas et al., 2006) These studies reveal that these indexes are also predictors 
of HF risk. Prospective epidemiological studies that investigated the association between 
obesity and HF were summarized in table 1. The results from these prospective studies 
consistently indicate that both general obesity and abdominal obesity increase the risk of HF. 
The increase in computerization and mechanization during the last decades has resulted in 
                                                   
1 This section originally appeared as Yujie Wang and Gang Hu. The individual and joint associations of obesity and 
physical activity on the risk of heart failure. Congestive Heart Failure, 16(6), 292-299, 2010. Reprinted by permission of 
John Wiley and Sons. http://onlinelibrary.wiley.com/doi/10.1111/j.1751-7133.2010.00189.x/abstract 
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ever-increasing numbers of people being sedentary for most of their time. In the US, more than 
one half of the adults do not engage in physical activity at the level currently recommended for 
health promotion.(Pate et al., 1995; Thompson et al., 2003) In response to this severe situation, 
three studies have looked into the association between regular physical activity and HF risk.(He 
et al., 2001; Hu et al., 2010b; Kenchaiah et al., 2009) Prospective epidemiological studies that 
investigated the association between physical activity and HF were summarized in table 2. 
The results from these prospective studies consistently indicate that regular physical activity 
reduces the risk of HF. However, most previous studies focused on leisure time physical 
activity alone and the evidence on other types of physical activity, such as occupational or 
commuting physical activity, is sparse. It is unclear whether different forms of physical 
activity are independently related to a reduced risk of incident HF, and the joint effects of 
different types of physical activity would reduce the risk of HF further.  
Coffee consumption and HF 
Coffee is one of the most widely consumed beverages in the world.(Popkin et al., 2006) 
It has been suggested that coffee consumption may be associated with the risk of coronary 
heart disease (CHD),(Wu et al., 2009) hypertension,(Corti et al., 2002; Jee et al., 1999; 
Lovallo et al., 2004; Noordzij et al., 2005; Winkelmayer et al., 2005) and lower  risk of type 
2 diabetes,(Tuomilehto et al., 2004; van Dam and Hu, 2005)all of which are known risk 
factors of HF.(Ho et al., 1993; Kannel et al., 1974; Levy et al., 1996) Two prospective 
studies have previously investigated the association between coffee consumption and HF risk 
among Swedish men.(Ahmed et al., 2009; Wilhelmsen et al., 2001) The first prospective 
study on the relation between coffee consumption and the risk of HF was conducted among  
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Table 1. Selected findings on the association between obesity and the risk of heart failure 
Author, year No. of heart failure cases 
/No. of participants* 
Age range 
(years) 
Follow-up Major findings, BMI (kg/m2)  
Hazard ratios (95% CI) 
Adjustment factors 
General obesity     
Chen et al, 
1999(Chen et 
al., 1999) 
173 (85M/88F) 
/1749 (718M/1031F) 
≥65 10-year BMI <24, HR 1.00 (reference) 
BMI 24-27.9, HR 1.1 (0.7-1.7) 
BMI ≥28, HR 1.8 (1.1-2.7) 
Sex, age, DM, pulse pressure, MI during 
follow-up, and  type of housing 
He et al，
2001(He et al., 
2001) 
1382 (741M/641F）
/13643(5545M/8098F) 
25-74 19-year Male 
BMI <27.8, HR 1.00 (reference) 
BMI ≥27.8, HR 1.23 (1.00-1.52) 
Female 
BMI <27.3, HR 1.00 (reference) 
BMI ≥27.3, HR 1.34 (1.10-1.64) 
Age, race, education level, smoking, regular 
alcohol consumption, SBP, low physical 
activity, hypertension, history of DM, history 
of valvular  heart disease, and history of CHD 
Kenchaiah et 
al, 
2002(Kenchaia
h et al., 2002) 
496 (238M/258F) 
/5881(2704M/3177F) 
 
55 (mean) 14-year each 1-unit increase in BMI 
Male, HR 1.05 (1.02-1.09) 
Female, HR 1.07 (1.04-1.10) 
Alcohol consumption, serum total cholesterol, 
presence or absence of current smoking, valve 
disease, hypertension, DM, ECG-LVH, and MI 
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Table 1 continued 
Ingelsson et al, 
2005(Ingelsson 
et al., 2005c) 
104M/1187M ≥70 8.9-year 
(median) 
each 1-SD increase in BMI 
HR 1.35 (1.11-1.65) 
DM, prior MI, hypertension, ECG-LVH, 
smoking, and serum cholesterol 
Ingelsson et al, 
2005(Ingelsson 
et al., 2005b) 
259M/2321M ≥50 28.8-year 
(median) 
each 1-SD increase in BMI 
HR 1.47 (1.31-1.65) 
Prior acute MI, hypertension, DM, ECG-LVH, 
smoking, and serum cholesterol 
Nicklas et al, 
2006(Nicklas 
et al., 2006) 
 
166 (73M/93F)/ 2435 
(1081M/1354F) 
 6.1-year 
(median) 
each 1-SD increase in BMI 
HR 1.25 (1.02-1.53) 
Age, sex, race, site, education, smoking, 
chronic obstructive pulmonary disease, 
inflammation, incident MI, homeostasis model 
assessment of insulin sensitivity index, DM, 
and hypertension 
Bahrami et al, 
2008(Bahrami 
et al., 2008) 
79/6814 (3204M/3610F) 45-84 4-year 
(median) 
BMI <30, HR 1.00 (reference) 
BMI ≥30, HR 1.83 (1.14-2.92) 
Age, gender, hypertension, DM, LVH, Serum 
total cholesterol, and current smoking,  
Loehr et al, 
2009(Loehr et 
al., 2009) 
1528(825M/703F) 
/14641(6632M/8009F) 
45-65 16-year 
(median) 
each 1-SD increase in BMI 
Male, HR 1.47 (1.39-1.57) 
Female, HR 1.49 (1.39-1.59) 
Age, alcohol use, educational level, smoking 
status, and center 
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Table 1 continued 
Kenchaiah et 
al, 
2009(Kenchaia
h et al., 2009) 
1109M/21094M 40-84 20.5-year BMI <25, HR 1.00 (reference) 
BMI 25-29.9, HR 1.49 (1.32-1.69) 
BMI ≥30, HR 2.80 (2.24-3.50) 
 
Age, smoking, alcohol consumption, parental 
history of MI, random assignment to aspirin or 
β-carotene, vigorous physical activity, history 
of hypertension, DM, and 
hypercholesterolemia   
Levitan et al, 
2009(Levitan 
et al., 2009a) 
1100 (718M/382F) 
/80360(43487M /36873F) 
45-79M 
/48-83F 
7-year 
(median) 
An interquartile range increase in BMI 
Male, HR 1.27 (1.19-1.36) 
Female, HR 1.12 (1.00-1.24) 
Age, education, smoking, alcohol 
consumption, total physical activity, 
postmenopausal hormone therapy, living alone, 
marital status, and family history of MI, 
hypertension, high cholesterol, and DM 
Hu et al, 
2010(Hu et al., 
2010b) 
3614 (1921M/1693F)/ 
59178 (28842M/30336F) 
25-74 18.4-year Male 
BMI <25, HR 1.00 (reference) 
BMI 25-29.9, HR 1.25 (1.12-1.39) 
BMI ≥30, HR 1.99 (1.74-2.27) 
Female 
BMI <25, HR 1.00 (reference) 
BMI 25-29.9, HR 1.33 (1.16-1.51) 
BMI ≥30, HR 2.06 (1.80-2.37) 
Age, study year, education, smoking, alcohol 
consumption, history of MI, valvular heart 
disease, DM, SBP, total cholesterol, and 
physical activity 
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Table 1 continued 
Abdominal obesity     
Ingelsson et al, 
2005(Ingelsson 
et al., 2005c) 
104M/1187M ≥70 8.9-year 
(median) 
each 1-SD increase in WC 
HR 1.36 (1.10-1.69) 
DM, prior MI, hypertension, smoking, ECG 
LVH, and serum total cholesterol  
Nicklas et al, 
2006(Nicklas 
et al., 2006) 
 
166 (73M/93F)/ 2435 
(1081M/1354F) 
 6.1-year 
(median) 
each 1-SD increase in WC 
HR 1.32 (1.12-1.55) 
each 1-SD increase in WTR 
HR 1.15 (0.96-1.36) 
Age, sex, race, site, education, smoking, 
chronic obstructive pulmonary disease, 
inflammation, incident MI, homeostasis model 
assessment of insulin sensitivity index, DM, 
and hypertension 
Bahrami et al, 
2008(Bahrami 
et al., 2008) 
79/6814 (3204M/3610F) 45-84 4-year 
(median) 
WC >102 cm in men, WC >88 cm in women 
HR 2.06 (1.25-3.41) 
Age, gender, hypertension, DM, LVH, Serum 
cholesterol, and current smoking,  
Loehr et al, 
2009(Loehr et 
al., 2009) 
1528(825M/703F) 
/14641(6632M/8009F) 
45-65 16-year 
(median) 
each 1-SD increase in WC 
Male, HR 1.52 (1.43-1.62) 
Female, HR 1.54 (1.44-1.66) 
each 1-SD increase in WHR 
Male, HR 1.50 (1.41-1.60) 
Female, HR 1.59 (1.46-1.72) 
Age, alcohol use, educational level, smoking 
status, and center 
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Table 1 continued 
Levitan et al, 
2009(Levitan 
et al., 2009a) 
1100(718M/382F) 
/80360(43487M /36873F) 
45-79M 
/48-83F 
7-year 
(median) 
An interquartile range increase in WC 
Male, HR 1.31 (1.21-1.42) 
Female, HR 1.20 (1.05-1.36) 
An interquartile range increase in WHR  
Male, HR 1.08 (1.00-1.17) 
Female, HR 1.02 (0.93-1.12) 
An interquartile range increase in WHtR  
Male, HR 1.28 (1.18-1.39) 
Female, HR 1.14 (1.00-1.31) 
Age, education, smoking, alcohol 
consumption, total physical activity, 
postmenopausal hormone therapy, living alone, 
marital status, and family history of MI, 
hypertension, high cholesterol, and DM 
Hu et al, 
2010(Hu et al., 
2010b) 
3614 (1921M/1693F)/ 
59178(28842M/30336F) 
25-74 18.4-year each 1-cm increase in WC 
Male, HR 1.03 (1.02-1.04) 
Female, HR 1.04 (1.03-1.05) 
each 0.1-unit increase in WHR 
Male, HR 1.48 (1.25-1.75) 
Female, HR 1.64 (1.31-2.04) 
Age, study year, education, smoking, alcohol 
consumption, history of MI, valvular heart 
disease, DM, SBP, total cholesterol, physical 
activity 
*The number of subjects are those were finally included in the analyses.  
Abbreviations: BMI=body mass index, CHD=coronary heart disease, DM=diabetes mellitus, ECG=Electrocardiograph, MI=myocardial 
infarction, SBP=systolic blood pressure, WC= waist circumference, WHR=waist-to-hip ratio, LVH=left ventricular hypertrophy, HR=hazard 
ratio, WTR=waist-to-thigh ratio.  
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Table 2. Selected findings on the association between physical activity and the risk of heart failure 
Author, year No. of heart failure 
cases /No. of 
participants* 
Age 
range 
(years) 
Follow-up Major findings 
Hazard ratios (95% CI) 
Adjustment factors 
He et al, 
2001(He et al., 
2001) 
1382 (741M/641F）
/13643(5545M/8098F) 
 
25-74 19-year Regular exercise, HR 1.00 
(reference) 
Low exercise,  
Male, HR 1.14 (0.94-1.38) 
Female, HR 1.31 (1.11-1.54) 
Age, race, education level, smoking, 
regular alcohol consumption, SBP, 
overweight, hypertension, history of 
DM, history of valvular  heart disease, 
and history of CHD 
Kenchaiah et al, 
2009(Kenchaiah 
et al., 2009) 
1109M/21094M 40-84 20.5-year Vigorous physical activity 
Low, HR 1.00 (reference) 
Active ≥1-3 times/mo, HR 0.82 
(0.70-0.96) 
Age, cigarette smoking, alcohol 
consumption, parental history of MI, 
random assignment to aspirin or 
β-carotene, BMI, the presence or 
absence of history of hypertension, DM, 
and hypercholesterolemia 
 
 
 
 
 
 
13 
 
Table 2 continued 
Hu et al, 
2010(Hu et 
al., 2010b) 
3614(1921M/1693F)/ 
59178(28842M/30336F) 
25-74 18.4-year Low exercise, HR 1.00 (reference) 
Moderate exercise,  
Male, HR 0.79 (0.68-0.92) 
Female, HR 0.86 (0.75-0.99) 
High exercise, 
Male, HR 0.69 (0.60-0.80) 
Female, HR 0.68 (0.59-0.78) 
Age, study year, education, smoking, 
alcohol consumption, history of MI, 
valvular heart disease, DM, SBP, total 
cholesterol, and BMI 
*The number of subjects are those were finally included in the analyses.  
Abbreviations: BMI=body mass index, CHD=coronary heart disease, DM=diabetes mellitus, MI=myocardial infarction, SBP=systolic blood 
pressure. 
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7,495 participants of the Multifactor Primary Prevention Study,in which the association of coffee 
consumption with HF were first studied in bivariate analysis and further studied in multiple 
logistic regression.(Wilhelmsen et al., 2001) Coffee consumption was classified into three 
categories: 0, 1-4, ≥5cups/day in the bivariate analysis. Result of this analysis indicated that 
coffee consumption is marginally associated with HF risk. When entered the multiple logistic 
regression model, coffee consumption was analyzed as a variable of two category (<5 cups/day 
and ≥5cups/day). Results of this analysis suggested that coffee consumption ≥5cups/day (relative 
risk = 1.17; 95% confidence interval [CI], 1.05-1.30, compared with coffee consumption <5 
cups/day) was an independent predictor of HF.(Wilhelmsen et al., 2001) In a cohort of Swedish 
men, a prospective cohort of 37,315 men aged 45-79 years old, Ahmed et al.(Ahmed et al., 2009) 
classified coffee consumption into five categories: <1 cup/day, 2 cups/day, 3 cups/day, 4 
cups/day and ≥ 5 cups/day. They did not find a significant association between coffee 
consumption and HF hospitalization and HF mortality. Furthermore, the authors conducted a 4 
degree of freedom likelihood ratio test to exam whether including coffee consumption added 
information to the model. Result of this likelihood ratio test confirmed that coffee consumption 
was not a significant predictor of HF events.(Ahmed et al., 2009) Results from the two previous 
studies were inconsistent.(Ahmed et al., 2009; Wilhelmsen et al., 2001)
 
Also, both studies were 
conducted in men, and it is unclear whether coffee consumption is an independent risk factor of 
HF in women. The Finnish population has the highest per capita coffee consumption in the 
world, at 11.4 kg/year.(World Resources Institute) Research into the potential health effects 
of coffee in this population is therefore of particular interest. 
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Lifestyle pattern and HF 
The respective influence of lifestyle factors on the risk of HF has been assessed in 
several studies. However, the joint association of lifestyle factors with the risk of HF remains 
unclear. There is only one recent cohort study which demonstrated that having a healthy 
lifestyle had a statistically independent association with a reduced lifetime risk of 
HF.(Djousse et al., 2009) This study was conducted on male physicians who certainly had 
higher health consciousness, which limited its generalizability. Further studies are needed in 
explaining the influence of modifiable lifestyle factors on the risk of HF in other populations. 
Also, it is unknown that if the joint associations between lifestyle factors and the risk of heart 
failure in people with underlying hypertension is similar with that in the general population.  
 
16 
 
CHAPTER 2. OCCUPATIONAL, COMMUTING AND LEISURE-TIME PHYSICAL 
ACTIVITY IN RELATIONS TO HEART FAILURE AMONG FINNISH MEN AND 
WOMEN
2
 
2.1 Introduction 
Heart Failure (HF) has emerged as a scourge throughout the developed and developing 
regions of the world (Nieminen and Harjola, 2005; Schocken et al., 2008a). According to the 
American Heart Association, 550,000 new cases occur in the U.S. each year, and more than 
5 million Americans have HF (Schocken et al., 2008a). Although there is strong evidence 
that regular physical activity has a protective effect against coronary heart disease and stroke 
(Bassuk and Manson, 2005), studies related to regular physical activity and HF are sparse, 
and the results of these studies are inconsistent (Djousse et al., 2009; He et al., 2001; 
Kenchaiah et al., 2009). Furthermore, physical activity has always been represented by 
leisure-time physical activity in studies related to the association between physical activity 
and HF (Djousse et al., 2009; He et al., 2001; Kenchaiah et al., 2009), whereas the 
relationship of HF with occupational or commuting physical activity remains unclear. The 
aim of this study is to examine whether occupational, commuting, or leisure-time physical 
activity are independently associated with a reduced HF risk, and moreover, how different 
combinations of physical activity affects the risk. 
2.2 Methods 
Subjects 
Seven independent population surveys were carried out in 6 geographic areas of Finland 
                                                   
2 This chapter originally appeared as Yujie Wang, Jaakko Tuomilehto, Pekka Jousilahti, Riitta Antikainen, Markku 
Mähönen, Peter T. Katzmarzyk, and Gang Hu. Occupational, commuting and leisure-time pphysical activity in relation to 
heart failure among Finnish men and women. Journal of the American College of Cardiology, 56(14), 1140-1148, 2010. 
Reprinted by permission of Elsevier. http://content.onlinejacc.org/article.aspx?articleid=1143710 
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in 1972, 1977, 1982, 1987, 1992, 1997 and 2002 (Vartiainen et al., 2000). In 1972 and 1977, 
a randomly selected sample of 6.6% of the population born between 1913 and 1947 was 
drawn. Since 1982, the sample was stratified by area, gender and 10-year age group 
according to the World Health Organization (WHO) Monitoring trends and determinants of 
Cardiovascular disease (MONICA) protocol (Pajak et al., 1988). The participation rate 
varied by year from 65% to 88% (Vartiainen et al., 2000). The subjects included in the seven 
surveys were 25 to 64 years of age, and the 1997 and 2002 surveys also included subjects 
aged 65 to 74 years. Subjects who participated in more than one survey were included only 
in the first survey cohort in which they appeared. The total sample size of the seven surveys 
was 62,013. After excluding 998 subjects with a history of HF at baseline, and 2807 with 
incomplete data on any required variables, the present analyses include 28,334 men and 
29,874 women. The participants provided an informed consent (verbal 1972-1992 and 
written 1997 and 2002). These surveys were conducted according to the ethical rules of the 
National Institute for Health and Welfare, and the investigations were performed in 
accordance with the Declaration of Helsinki. 
Assessment of physical activity 
Occupational, commuting, and leisure-time physical activity levels were assessed using 
a self-administered questionnaire only at baseline. A detailed description of the questions has 
been presented elsewhere (Hu et al., 2004b; Hu et al., 2007a; Hu et al., 2003; Hu et al., 
2005b). The questionnaire used for the assessment of physical activity has been successfully 
used elsewhere and it has shown a high correlation with physical fitness, as measured by 
maximal oxygen uptake.(Albanes et al., 1990; Andersen et al., 2000) The subjects reported 
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their occupational physical activity according to the following three categories: (i) ‘low’ was 
physically very easy, sitting office work, e.g. secretary; (ii) ‘moderate’ was work including 
standing and walking, e.g. store assistant, light industrial worker; (iii) ‘high’ was work 
including walking and lifting, or heavy manual labor, e.g. industrial or farm work. Daily 
commuting (return journey) was categorized into three categories: (i) motorized 
transportation or no physical work (no walking or cycling); (ii) walking or bicycling 1 to 
29 minutes per day; (iii) walking or bicycling more than 30 minutes per day. Self-reported 
leisure-time physical activity was classified into three categories: (i) ‘low’ was defined as 
almost completely inactive, such as reading, watching TV, or doing some minor physical 
activity but not of moderate or high level; (ii) ‘moderate’ was doing some physical activity 
more than four hours a week, such as walking, cycling, or light gardening, excluding travel 
to work; (iii) ‘high’ was performing vigorous physical activity more than three hours a week, 
such as running, jogging, swimming, or heavy gardening, or competitive sports several times 
a week.  
Other assessments 
Smoking, socioeconomic factors, alcohol consumption, and medical history were also 
assessed by using the self-administered questionnaire. Based on the questionnaire data, the 
participants were classified as never smokers, ex-smokers and current smokers. Current 
smokers were categorized into those who smoked <20 or ≥20 cigarettes per day. Years of 
education were divided into birth cohort specific tertiles. Since questions on alcohol 
consumption were different between the first two surveys (1972 and 1977) and the latter 
surveys, the participants were categorized into abstainers and alcohol users. Data on the 
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initiation of antihypertensive drug treatment were obtained from the questionnaire and the 
records of drug register. Subjects who reported having diabetes on the questionnaire, or who 
had had a hospital discharge diagnosis of diabetes (including asymptomatic diabetes and 
known diabetes), or who received the approval of a physician for using diabetes medication 
(either oral glucose-lowering agents or insulin) before the baseline survey were classified as 
having history of diabetes at baseline (Hu et al., 2003). Data on the history of myocardial 
infarction at baseline were obtained from the questionnaire and collected by hospital 
discharge diagnosis, and the overall sensitivity of the diagnosis of myocardial infarction in 
the FINNISH Hospital Discharge Register was 83% (Pajunen et al., 2005). Data on the 
history of valvular heart disease at baseline were collected by hospital discharge register. 
Data on the history of lung disease (pulmonary emphysema, bronchitis, chronic bronchial 
catarrh) were collected from the questionnaire. 
At the study site, trained research nurses measured height, weight, and blood pressure 
using a standardized protocol (Pajak et al., 1988). Height was measured without shoes and 
weight was measured with light clothing. Body mass index (BMI) was calculated by 
dividing weight in kilograms by the square of height in meters. Blood pressure was measured 
from the right arm after five minutes of sitting. After blood pressure measurement, a venous 
blood specimen was taken. Total cholesterol was determined by using Lieberman Burchard 
method in 1972 and 1977 and by an enzymatic method (CHOD-PAP, Boehringer 
MANNHEIM, Mannheim, Germany) since 1982. Because the enzymatic method gave 2.4% 
lower values than the Lieberman Burchard method (based on the double measurements of 
serum samples during the change of laboratory method), the values measured in 1972 and 
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1977 were corrected by this percentage. All samples were analyzed in the same central 
laboratory. 
Prospective Follow-up 
Follow-up information was obtained from the Finnish Hospital Discharge Register and 
the National Social Insurance Institution’s Register on special reimbursement for HF drugs 
for non-fatal outcomes and the Finnish Death Register for fatal outcomes by using social 
security numbers assigned to every citizen of Finland. The International Classification of 
Diseases (ICD) codes 427.00 and 427.10 (ICD-8), 428, 4029B (hypertensive heart disease 
with HF) and 4148A-X (ischemic HF with chronic coronary heart disease) (ICD-9), and I 50, 
I11.0 (hypertensive heart disease with HF), I13.0 and I13.2 (hypertensive heart and renal 
disease with HF) (ICD-10) were used to identify cases in the above national databases. A HF 
diagnosis was made by the treating physicians, based on a clinical assessment, X-ray 
examination and, to various extents, echocardiography. Follow-up of each cohort member 
continued until the date of the diagnosis of HF obtained from the Hospital Discharge 
Register, the National Social Insurance Institution’s Register or mortality, death from causes 
other than HF, or December 31, 2006 (Hu et al., 2010a). This diagnosed method has been 
used in other Scandinavian countries, such as Sweden. The accuracy of the HF cases in the 
Swedish hospital discharge is found to be over 80% based on the European Society of 
Cardiology (ESC) definition.(Ingelsson et al., 2005a; Levitan et al., 2009a) 
Statistical analyses 
Differences in risk factors between groups with different physical activity levels were 
tested using univariate analysis of variance (ANOVA) after adjustment for age and study 
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year. Cox proportional hazards regression models were used to analyze the association of 
physical activity with the risk of HF. Physical activity categories were included in the 
models as dummy and categorical variables, and the significance of the trend over different 
categories of physical activity was tested in the same models by giving an ordinal numeric 
value for each dummy variable. The proportional hazards assumption in the Cox model was 
assessed with graphical methods, and with models including time-by-covariate interactions 
(Cox, 1972). In general, all proportionality assumptions were appropriate. The analyses were 
first carried out adjusting for age and study year, and further for smoking, education, alcohol 
consumption, history of myocardial infarction, history of valvular heart disease, history of 
diabetes, history of using anti-hypertensive drugs, history of lung disease, BMI, systolic 
blood pressure, and total cholesterol, and further for other two types of physical activity. To 
avoid a potential bias due to severe disease at baseline, additional analyses were carried out 
excluding the subjects who died during the first two years of follow-up (n=408). Statistical 
significance was considered to be P<0.05. Statistical package SPSS for Windows, version 
17.0 (SPSS Inc, Chicago, III), was used for statistical analysis. 
2.3 Results  
During a mean follow-up of 18.4 years, 1868 men and 1640 women developed HF. 
General characteristics of the study population by different types of physical activity at 
baseline are presented in Table 3. Age- and study year-adjusted partial correlations were 0.23 
in men (P<0.001) and 0.20 in women (P<0.001) for occupational and commuting physical 
activity, -0.08 in men (P<0.001) and -0.04 in women (P<0.001) for occupational and 
leisure-time physical activity, and 0.03 in men (P<0.001) and 0.06 in women (P<0.001) for 
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commuting and leisure-time physical activity. 
Age- and study year-adjusted hazard ratios (HRs) of HF associated with low, moderate 
and high occupational physical activity were 1.00, 0.75, and 0.74 (P<0.001 for trend) for 
men, and 1.00, 0.67, and 0.87 (P<0.001 for trend) for women, respectively (Table 4). In 
multivariable analyses, after further adjustment for other risk factors (smoking, education, 
alcohol consumption, history of myocardial infarction, history of valvular heart disease, 
history of diabetes, history of using anti-hypertensive drugs, history of lung disease, BMI, 
systolic blood pressure, and total cholesterol), and for commuting and leisure-time physical 
activity, these inverse associations were still statistically significant for men (P=0.005 for 
trend) and women (P=0.007 for trend).  
Daily commuting physical activity on foot or by bicycle was significantly and inversely 
associated with the risk of HF among men (P<0.001 for trend) and women (P<0.001 for 
trend) after adjustment for age and study year (Table 5). The inverse relationship remained 
significant among women (P=0.008 for trend) but not among men (P=0.374 for trend) after 
further adjustment for other risk factors. Women spending daily 1-29 minutes in walking or 
cycling to and from work had a significantly reduced risk of HF than women who had no 
commuting activity after additional adjustment for occupational and leisure-time physical 
activity.  
Age- and study year-adjusted HRs of HF associated with low, moderate and high 
leisure-time physical activity were 1.00, 0.81, and 0.53 (P<0.001 for trend) in men, and 1.00 
0.71, and 0.56 (P<0.001 for trend) in women, respectively (Table 6). These inverse 
associations weakened to some extent, but remained statistically significant, after further  
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Table 3. General characteristics of study subjects at baseline* 
 
Occupational physical  activity 
Men P for 
trend 
Women P for 
trend Low Moderate High Low Moderate High 
No. of subjects 11,069 6,032 11,233  13,115 9,266 7,493  
Age at baseline (yrs) 48.5 42.2 43.0 <0.001 46.8 42.4 44.2 <0.001 
Body mass index (kg/m
2
) 26.5 26.4 26.3 0.003 26.0 25.7 26.6 <0.001 
Diastolic blood pressure (mm Hg) 87 87 86 0.002 83 83 84 <0.001 
Systolic blood pressure (mm Hg) 143 142 143 <0.001 138 137 140 <0.001 
Serum cholesterol (mmol/l) 6.01 6.04 6.19 <0.001 5.96 5.89 6.09 <0.001 
Education (yrs) 10.4 10.6 8.3 <0.001 10.3 10.6 9.1 <0.001 
Alcohol drinker (%) 66.3 77.1 63.6 <0.001 40.6 43.4 32.0 <0.001 
Current smoker (%) 41.8 36.6 43.2 <0.001 19.3 18.7 16.3 <0.001 
History of myocardial infarction (%) 5.5 2.8 1.9 <0.001 1.6 0.6 0.4 <0.001 
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Table 3 continued 
History of valvular heart disease (%) 0.1 0.2 0.1 0.36 0.1 0.1 0.0 0.013 
History of diabetes (%) 3.3 2.4 1.7 <0.001 2.6 1.4 1.7 <0.001 
History of using anti-hypertensive drugs (%) 12.3 9.5 7.9 <0.001 13.6 9.5 9.9 <0.001 
History of lung disease (%) 7.5 4.5 5.3 <0.001 5.1 4.6 4.9 0.261 
 
  
Commuting physical activity 
Men P for 
trend 
Women P for 
trend 0 1-29 ≥30 0 1-29 ≥30 
No. of subjects 15,288 8,565 4,481  13,650 9,609 6,615  
Age at baseline (yrs) 46.2 42.2 46.0 <0.001 47.1 42.1 43.9 <0.001 
Body mass index (kg/m
2
) 26.5 26.3 26.1 <0.001 26.5 25.8 25.6 <0.001 
Diastolic blood pressure (mm Hg) 87 87 87 0.63 83 83 83 0.33 
Systolic blood pressure (mm Hg) 143 142 142 <0.001 139 137 137 <0.001 
Serum cholesterol (mmol/l) 6.10 6.09 6.07 0.22 6.02 5.92 5.94 <0.001 
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Table 3 continued 
Education (yrs) 9.4 10.0 9.6 <0.001 9.6 10.5 10.4 <0.001 
Alcohol drinker (%) 65.7 67.5 65.8 0.012 35.0 44.0 41.5 <0.001 
Current smoker (%) 43.5 38.1 39.6 <0.001 18.3 19.0 17.7 0.093 
History of myocardial infarction (%) 4.6 2.2 2.1 <0.001 1.5 0.6 0.5 <0.001 
History of valvular heart disease (%) 0.1 0.2 0.1 0.46 0.1 0.0 0.1 0.049 
History of diabetes (%) 2.7 2.1 2.5 0.009 2.5 1.6 1.2 <0.001 
History of using anti-hypertensive drugs (%) 10.9 9.2 8.7 <0.001 13.1 10.3 9.5 <0.001 
History of lung disease (%) 6.9 4.9 4.9 <0.001 5.1 4.6 4.9 0.158 
 Leisure-time physical activity 
Men  Women  
Low Moderate High Low Moderate High 
No. of subjects 7,849 14,761 5,724  10,564 15,032 4,278  
Age at baseline (yrs) 45.5 46.3 41.0 <0.001 45.7 45.2 41.3 <0.001 
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Table 3 continued 
Body mass index (kg/m
2
) 26.7 26.5 25.7 <0.001 26.9 25.8 25.0 <0.001 
Diastolic blood pressure (mm Hg) 87 87  85 <0.001 84 83 82 <0.001 
Systolic blood pressure (mm Hg) 143 143 141 <0.001 139 138 136 <0.001 
Serum cholesterol (mmol/l) 6.15 6.14 5.88 <0.001 6.01 5.96 5.90 <0.001 
Education (yrs) 9.1 9.5 10.6 <0.001 9.7 10.2 10.7 <0.001 
Alcohol drinker (%) 63.1 66.8 69.3 <0.001 36.5 39.8 44.6 <0.001 
Current smoker (%) 50.0 41.8 27.8 <0.001 21.6 17.8 12.4 <0.001 
History of myocardial infarction (%) 3.9 3.7 2.5 <0.001 1.4 0.9 0.5 <0.001 
History of valvular heart disease (%) 0.1 0.2 0.1 0.060 0.1 0.1 0.1 0.74 
History of diabetes (%) 3.2 2.3 1.8 <0.001 2.3 1.9 1.1 <0.001 
History of using anti-hypertensive drugs (%) 10.7 10.4 7.7 <0.001 13.1 11.0 8.1 <0.001 
History of lung disease (%) 7.7 5.6 4.6 <0.001 5.7 4.6 3.9 <0.001 
*Baseline characteristics represent mean or percentage; adjusted for age and study year. 
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Table 4. Hazard ratios of heart failure according to different levels of occupational physical activity 
 Occupational physical  activity P for trend 
Low Moderate High 
Men 11,069 6,032 11,233  
    No. of incidence case 777 340 751  
    Person-yrs 160,376 117,247 225,292  
    Age and study years adjusted HR (95% CI) 1.00 0.75 (0.66-0.85) 0.74 (0.67-0.82) <0.001 
    Multivariable adjustment HR (95% CI)* 1.00 0.88 (0.77-1.01) 0.84 (0.75-0.94) 0.006 
    Multivariable adjustment HR (95% CI)† 1.00 0.90 (0.78-1.03) 0.83 (0.73-0.93) 0.005 
Women 13,115 9,266 7,493  
    No. of incidence case 759 358 523  
    Person-yrs 216,737 189,921 159,959  
    Age and study years adjusted HR (95% CI) 1.00 0.67 (0.59-0.76) 0.87 (0.78-0.97) <0.001 
    Multivariable adjustment HR (95% CI)* 1.00 0.77 (0.67-0.87) 0.90 (0.80-1.01) <0.001  
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Table 4 continued 
    Multivariable adjustment HR (95% CI)† 1.00 0.80 (0.70-0.92) 0.92 (0.82-1.05) 0.007 
Men and women combined‡ 24,184 15,298 18,726  
    No. of incidence case 1,536 698 1,274  
    Person-yrs 377,113 307,168 385,251  
    Age and study years adjusted HR (95% CI) 1.00 0.70 (0.64-0.77) 0.79 (0.74-0.85) <0.001 
    Multivariable adjustment HR (95% CI)* 1.00 0.82 (0.74-0.90) 0.86 (0.79-0.93) <0.001 
    Multivariable adjustment HR (95% CI)† 1.00 0.85 (0.77-0.93)  0.87 (0.80-0.94) <0.001 
HR = hazard ratio; CI = confidence interval. 
*Adjusted for age, study year, education, smoking, alcohol consumption, history of myocardial infarction, history of valvular heart disease, 
history of diabetes, systolic blood pressure, total cholesterol, history of using anti-hypertension drugs, history of lung disease and BMI. 
†Adjusted for age, study year, education, smoking, alcohol consumption, history of myocardial infarction, history of valvular heart disease, 
history of diabetes, systolic blood pressure, total cholesterol, history of using anti-hypertensive drugs, history of lung disease, BMI, and other 
two types of physical activity. 
‡Adjusted also for sex. 
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Table 5. Hazard ratios of heart failure according to different levels of commuting physical activity 
 Walking or cycling to and from work (minutes/day) P for trend 
0 1-29 ≥30 
Men 15,288 8,565 4,481  
    No. of incidence case 984 499 385  
    Person-yrs 243,541 167,513 91,861  
    Age and study years adjusted HR (95% CI) 1.00 0.83 (0.74-0.92) 0.81 (0.72-0.91) <0.001 
    Multivariable adjustment HR (95% CI)* 1.00 0.96 (0.86-1.07) 0.92 (0.81-1.04) 0.374 
    Multivariable adjustment HR (95% CI)† 1.00 1.01 (0.90-1.13) 0.99 (0.87-1.12) 0.954 
Women 13,650 9,609 6,615  
    No. of incidence case 959 351 330  
    Person-yrs 237,004 192,706 136,906  
    Age and study years adjusted HR (95% CI) 1.00 0.73 (0.64-0.82) 0.76 (0.67-0.86) <0.001 
    Multivariable adjustment HR (95% CI)* 1.00 0.83 (0.73-0.94) 0.89 (0.78-1.01) 0.008 
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Table 5 continued 
    Multivariable adjustment HR (95% CI)† 1.00 0.87 (0.76-0.99) 0.94 (0.82-1.07) 0.108 
Men and women combined‡ 28,938 18,174 11, 096  
    No. of incidence case 1,943 850 715  
    Person-yrs 480,545     360,220 228,767  
    Age and study years adjusted HR (95% CI) 1.00 0.77 (0.71-0.83) 0.76 (0.70-0.83) <0.001 
    Multivariable adjustment HR (95% CI)* 1.00 0.88 (0.81-0.96) 0.88 (0.80-0.96) 0.001 
    Multivariable adjustment HR (95% CI)† 1.00 0.93 (0.85-1.01) 0.93 (0.85-1.02) 0.159 
HR = hazard ratio; CI = confidence interval. 
*Adjusted for age, study year, education, smoking, alcohol consumption, history of myocardial infarction, history of valvular heart disease, 
history of diabetes, systolic blood pressure, total cholesterol, history of using anti-hypertension drugs, history of lung disease and BMI. 
†Adjusted for age, study year, education, smoking, alcohol consumption, history of myocardial infarction, history of valvular heart disease, 
history of diabetes, systolic blood pressure, total cholesterol, history of using anti-hypertensive drugs, history of lung disease, BMI, and other 
two types of physical activity. 
‡Adjusted also for sex. 
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Table 6. Hazard ratios of heart failure according to different levels of leisure time physical activity 
 Leisure time physical activity P for trend 
Low Moderate High 
Men 7,849 14,761 5,724  
    No. of incidence case 707 995 166  
    Person-yrs 140,606 260,215 102,094  
    Age and study years adjusted HR (95% CI) 1.00 0.81 (0.73-0.88) 0.53 (0.45-0.62) <0.001 
    Multivariable adjustment HR (95% CI)* 1.00 0.84 (0.76-0.93) 0.66 (0.55-0.79) <0.001 
    Multivariable adjustment HR (95% CI)† 1.00 0.83 (0.76-0.92) 0.65 (0.54-0.77) <0.001 
Women 10,564 15,032 4,278  
    No. of incidence case 940 608 92  
    Person-yrs 219,722 273,837 73,058  
    Age and study years adjusted HR (95% CI) 1.00 0.71 (0.65-0.79) 0.56 (0.46-0.69) <0.001 
    Multivariable adjustment HR (95% CI)* 1.00 0.83 (0.74-0.92) 0.74 (0.59-0.92) <0.001 
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Table 6 continued 
    Multivariable adjustment HR (95% CI)† 1.00 0.84 (0.75-0.93) 0.75 (0.60-0.94) 0.001 
Men and women combined‡ 18,413 29,793 10,002  
    No. of incidence case 1,647 1,603 258  
    Person-yrs 360,328 534,052 175,151  
    Age and study years adjusted HR (95% CI) 1.00 0.75 (0.70-0.81) 0.54 (0.48-0.61) <0.001 
    Multivariable adjustment HR (95% CI)* 1.00 0.83 (0.77-0.89) 0.69 (0.60-0.79) <0.001 
    Multivariable adjustment HR (95% CI)† 1.00 0.83 (0.77-0.89) 0.69 (0.60-0.79) <0.001 
HR = hazard ratio; CI = confidence interval. 
*Adjusted for age, study year, education, smoking, alcohol consumption, history of myocardial infarction, history of valvular heart disease, 
history of diabetes, systolic blood pressure, total cholesterol, history of using anti-hypertension drugs, history of lung disease and BMI. 
†Adjusted for age, study year, education, smoking, alcohol consumption, history of myocardial infarction, history of valvular heart disease, 
history of diabetes, systolic blood pressure, total cholesterol, history of using anti-hypertensive drugs, history of lung disease, BMI, and other 
two types of physical activity. 
‡Adjusted also for sex. 
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Figure 1. Hazard rations of heart failure according to joint categories of occupational, commuting andleisure-time physical activity among men 
(A) and women (B). 
Adjusted for age, study year, education, smoking, alcohol consumption, history of myocardial infarction, history of valvular heart disease, 
history of diabetes, history of using anti-hypertensive drugs, history of lung disease BMI, systolic blood pressure, and total cholesterol. 
*p<0.05 
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adjustment for other risk factors and occupational and commuting physical activity (both 
P<0.001 for trend).  
The joint effects of different types of physical activity on the risk of HF are presented in 
Figure 1. We dichotomized the level of occupational and leisure-time physical activity at low 
versus moderate to high and the level of commuting physical activity as any versus none. 
Among men, both moderate or high levels of leisure-time physical activity and moderate or 
high levels of occupational physical activity had inverse associations with HF risk. The 
combination of any two types of physical activity or the made this favorable effect even 
bigger. Among women, none of the three types of physical activity alone is significantly 
associated with a reduced risk of HF. However, the risk of HF significantly reduced among 
women with more than one type of physical activity. After adjustment for age, study year, 
and other risk factors, men with high levels of all three types of physical activity had a 31% 
lower risk of HF as compared with the least active men. In women, the risk reduction was 
34%.  
Exclusion of the participants who died during the first two years of follow-up did not 
appreciably change the results above. 
2.4 Discussion 
Moderate and high levels of occupational or leisure-time physical activity are associated 
with a reduced risk of HF in both sexes. Commuting activity was inversely associated with 
HF risk among women before adjustment for occupational and leisure time physical activity. 
A simultaneous engagement in two or three types of physical activity showed a slightly 
stronger protective effect than participation in only one type of physical activity. 
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To the best of our knowledge, only three studies have assessed the association between 
physical activity and the risk of HF (Djousse et al., 2009; He et al., 2001; Hu et al., 2010a; 
Kenchaiah et al., 2009), and only one of them included both men and women (He et al., 
2001). Moreover, the results of the three studies were inconsistent.(Djousse et al., 2009; He 
et al., 2001; Hu et al., 2010a; Kenchaiah et al., 2009) Physical activity was found to be a 
protective factor against HF among men in the Physicians’ Health Study.(Djousse et al., 
2009; Kenchaiah et al., 2009)  On the other hand, in the First National
 
Health and Nutrition 
Examination Survey, the significant inverse association between leisure-time physical 
activity and HF risk was found only in women but not in men(He et al., 2001). In the present 
study, for the first time, moderate or high physical activity levels were found to be associated 
with a decreased risk of HF in both men and women.  
All of the previous studies focused on leisure-time activity. (Djousse et al., 2009; He et 
al., 2001; Kenchaiah et al., 2009) However, the present study shows for the first time that 
moderate or high occupational physical activity also has the same protective effect on the 
risk of HF as leisure-time physical activity, especially in men. If this finding represents a 
causal relation, this approach is highly relevant to the improvement of health and longevity 
among working-aged people, because the increase in computerization and mechanization 
during the last decades has resulted in ever-increasing numbers of people being sedentary for 
most of their working time. Occupational physical activity has been largely ignored in 
epidemiological surveys. The National Institutes of Health Consensus Development 
Conference on Physical Activity and Cardiovascular Health concluded that intermittent or 
shorter bouts of physical activity (at least 10 minutes), including occupational and 
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non-occupational activity and tasks of daily living, have similar HF preventive effects and 
other health benefits if performed at a level of moderate intensity (such as brisk walking, 
cycling, swimming, home repair, and yard work) with an accumulated duration of at least 30 
minutes per day (NIH Consensus Development Panel on Physical Activity and 
Cardiovascular Health, 1996).  
The present study is also the first study which observed an association between 
commuting physical activity and the risk of HF. We observed the significant inverse 
association between active commuting with the risk of HF events in women before 
adjustment for occupational and leisure time physical activity. Although we did not establish 
a significant association between the risk of HF and commuting physical activity alone in 
both men and women, we confirmed that an individual with moderate or high leisure-time or 
occupational physical activity experienced further reduced risk of HF, when he was also 
engaged in commuting physical activity. This is an important finding because daily active 
commuting is a major source of total physical activity in some populations, can be 
implemented virtually everywhere, and is inexpensive. For example, in urban China more 
than 90% of people walk or cycle to and from work daily (Hu et al., 2002) . In our study, 
54% of women and 46% of men reported walking or cycling to work daily, and 22% of 
women and 16% of men reported more than a half hour walking or cycling to work daily. 
Several studies have shown that regular walking or cycling to and from work is related to 
lower levels of cardiovascular risk factors (Hu et al., 2001; Hu et al., 2002; Hu et al., 2003), 
as well as a reduced risk of type 2 diabetes (Hu et al., 2003), stroke (Hu et al., 2005b), and 
CHD incidences (Hu et al., 2007a), and mortality in general populations and patients with 
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diabetes (Andersen et al., 2000; Hu et al., 2004b). In many Western studies, commuting 
physical activity was indirectly measured by asking for the frequency and duration of 
walking or cycling. Our results emphasize commuting as a separate component of physical 
activity to prevent HF in women. 
The differences between the results of the present study and the previous studies may be 
partially explained by the relatively larger sample size of both men and women; the inclusion 
of physical activity during occupation, commuting, and leisure time; more incident HF cases; 
and different adjustment procedures in the present study. When assessing the joint effects of 
different types of physical activity, we observed a slightly higher risk of HF in those who 
participated in three types of physical activity. By our classification, it was possible that the 
level of the three types of physical activity in which those participants engaged were 
moderate levels of physical activity, while it is also possible for participants to take part in 
two types of physical activity the level of which were high levels of physical activity. This 
may partly account for the observed trend. Moreover, the present study indicated that the 
lowest hazard ratios occurred in women who did moderate occupational and commuting 
physical activity. Older age and higher levels of CVD risk factors in women with high 
occupational physical activity compared with women with moderate occupational physical 
activity may partly account for the observed trend although we took these CVD risk factors 
into account in the multivariable analyses. Except for older age, other possible reasons for 
the loss of dose effect between commuting physical activity and HF risk among women in 
our study was unknown. 
The protective effect of physical activity to HF may be partly mediated by its effect on 
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other risk factors for HF. Physical activity has a favorable effect on blood pressure, lipid 
profile, insulin sensitivity, body weight, blood coagulation, and fibrinolysis (Gris et al., 1990; 
Hu et al., 2004a; Hu et al., 2007a; Hu et al., 2001; Hu et al., 2002; Mayer-Davis et al., 1998), 
and it is also contributed to a decreased risk of developing hypertension, type 2 diabetes, the 
metabolic syndrome and CHD (Hu et al., 2004a; Hu et al., 2007a; Hu et al., 2003; Hu et al., 
2007c; Laaksonen et al., 2002; Tuomilehto et al., 2001). In our study population, it has been 
previously shown that moderate or high levels of occupational or leisure-time physical 
activity were associated with a reduced risk of CHD, and daily walking or cycling to and 
from work was associated with a decreased risk of CHD among women (Hu et al., 2007a; Hu 
et al., 2007c). The current findings on the relationship between physical activity and the risk 
of HF are similar with the previous findings about the association between physical activity 
and the risk of CHD.  In the present study, the inverse association between physical activity 
and the risk of HF remained after adjusting for major HF risk factors. However, given the 
temporal lag between the assessment of physical activity at baseline and the measurement of 
the outcome, it is not possible to determine the pathways by which physical activity resulted 
in lower risk of HF.    
      There are several strengths and limitations in our study. First, a major strength of the 
study is the large number of both men and women from a homogeneous population who 
participated in the study. Second, the mean follow-up time was sufficiently long to ascertain 
a large number of HF endpoint events. Not only leisure-time physical activity, but also 
occupational and commuting physical activities were included in the analysis. Finally, we 
also carried out additional analyses excluding the subjects who died during the first two 
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years of follow-up to avoid a potential bias due to a severe disease at baseline. A limitation 
of our study is the self-report of physical activity, and that physical activity was recorded 
only once at baseline. Although no specific assessment of repeatability or validity of our 
questionnaire for physical activity has been carried out, similar questionnaires have been 
used in a large number of studies in Finland and other Nordic countries (Andersen et al., 
2000; Hu et al., 2004b; Hu et al., 2007a; Hu et al., 2003; Hu et al., 2005b) where the patterns 
of physical activity are relatively similar. The method has been working in a large number of 
studies that can be considered as a validation in practice.(Albanes et al., 1990; Andersen et 
al., 2000) We have no data on possible changes in physical activity during the follow-up. 
Misclassification, particularly over-reporting of the amount of physical activity at baseline 
and changes in the activity during the follow-up probably underestimated the association 
between physical activity and the outcome. Because our data allowed for only a 
dichotomized measure of alcohol consumption in the whole sample, we may not be able to 
fully control for the effect of this variable on the risk of HF. In order to evaluate the impact 
of this shortcoming we performed separate subgroup analyses (surveys of 1982, 1987, 1992, 
1997 and 2002) in the multivariable-adjusted model of a dichotomized measure of alcohol 
consumption compared with another multivariable-adjusted model of 4 categories of alcohol 
consumption. In general, the associations between different types of physical activity and HF 
risk were not influenced substantially or systematically. Ascertainment of HF status was 
based on the National Hospital Discharge Registry, the National Social Insurance 
Institution’s Register on special reimbursement for HF drugs, and Causes of Death Register. 
This diagnosis method has been used in other Scandinavian countries, such as Finland and 
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Sweden (Hu et al., 2010a; Ingelsson et al., 2005a; Levitan et al., 2009a; Wang et al., 2009). 
The accuracy of the HF cases in the Swedish hospital discharge is found to be over 80% 
based on the ESC definition (Ingelsson et al., 2005a; Levitan et al., 2009a). Although 
accuracy of clinical HF diagnosis in our cohort is likely to be high, some diagnostic errors 
are inevitable. However, the misdiagnosis is most likely to be independent of the exposure 
status and therefore tends to attenuate the underlying associations rather than cause spurious 
associations. We cannot completely either exclude the effects of residual confounding due to 
measurement error in the assessment of confounding factors, or some unmeasured  factors, 
such as other chronic diseases (e.g., peripheral vascular disease, renal disease, and anemia), 
the extent or severity of the prior MI, ischemic heart disease symptom burden, and some 
dietary factors.  
In conclusion, our study confirms that moderate or high levels of occupational or 
leisure-time physical activity have negative association with the risk of HF among men and 
women. Active commuting had a significant inverse association with the risk of HF events in 
women before adjustment for occupational and leisure time physical activity. 
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CHAPTER 3. COFFEE CONSUMPTION AND THE RISK OF HEART FAILURE IN 
FINNISH MEN AND WOMEN
3
 
3.1 Introduction 
Heart failure (HF) has emerged as a major and growing health problem both in the 
developed and developing regions of the world.(Schocken et al., 2008a) Although use of 
medication has reduced re-hospitalization rates and mortality from HF, HF is still the leading 
cause of hospitalization for older people in the United States,(Kozak et al., 2006) and 
mortality among HF patients has remained substantial, with approximately one quarter of 
patients dying within one year and half within five years of diagnosis. Therefore, the 
prevention of HF through lifestyle approaches is an important public health consideration.  
Coffee is one of the most widely consumed beverages in the world.(Popkin et al., 2006) 
It has been suggested that coffee consumption may be associated with the risk of coronary 
heart disease (CHD),(Wu et al., 2009) hypertension,(Noordzij et al., 2005) and type 2 
diabetes.(Tuomilehto et al., 2004; van Dam and Hu, 2005) Two prospective studies have 
previously investigated the association between coffee consumption and HF risk among 
Swedish men.(Ahmed et al., 2009; Wilhelmsen et al., 2001) One showed that coffee 
consumption increased the risk of HF,(Wilhelmsen et al., 2001) while the other found an null 
association between coffee consumption and the risk of HF.(Ahmed et al., 2009) Also, both 
studies were conducted in men, and it is unclear whether coffee consumption is an independent 
risk factor of HF in women. The Finnish population has the highest per capita coffee 
consumption in the world, at 11.4 kg/year.(World Resources Institute) Therefore, the aim of 
                                                   
3 This chapter originally appeared as Yujie Wang, Jaakko Tuomilehto, Pekka Jousilahti, Riitta Antikainen, Markku 
Mähönen, Satu Männistö, Peter T. Katzmarzyk, and Gang Hu. Coffee consumption and the risk of heart failure in Finnish 
men and women. Heart, 97(1), 44-48, 2010. Reprinted by permission of BMJ Group. 
http://heart.bmj.com/content/early/2010/10/26/hrt.2010.206045 
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this study was to examine the association of coffee consumption with the risk of HF in a 
large prospective cohort of Finnish men and women.  
3.2 Methods 
Subjects 
Seven independent cross-sectional population surveys were carried out in six geographic 
areas of Finland in 1972, 1977, 1982, 1987, 1992, 1997 and 2002.(Vartiainen et al., 2000) In 
1972 and 1977, a randomly selected sample making up 6.6% of the population born between 
1913 and 1947 was drawn. Since 1982, the sample was stratified by area, gender and 10-year 
age group according to the World Health Organization (WHO) MONICA (MONItoring trends 
and determinants of CArdiovascular disease) protocol.(Pajak et al., 1988) The participation 
rate varied by year from 65% to 88%.(Vartiainen et al., 2000) The subjects included in the 
seven surveys were 25 to 64 years of age, and the 1997 and 2002 surveys also included 
subjects aged 65 to 74 years. Subjects who participated in more than one survey were included 
only in the first survey cohort. The total sample size of the seven surveys was 62,013. After 
excluding 998 subjects with a history of HF at baseline, and 1525 with incomplete data on any 
required variables, the present analyses include 28,837 men and 30,653 women. The 
participants provided an informed consent (verbal from 1972 to 1992 and written 1997 and 
2002). These surveys were conducted according to the ethical rules of the National Public 
Health Institute, and the investigations were performed in accordance with the Declaration of 
Helsinki. 
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Baseline measurements 
A self-administered questionnaire was mailed to the participants to be completed at home 
and returned to the survey site. The questionnaire included questions on medical history, 
socioeconomic factors, physical activity, smoking habits, and alcohol consumption. Education 
level, measured as the total number of school years, was divided into birth cohort specific 
tertiles. Physical activity included occupational, commuting, and leisure time physical 
activity. A detailed description of the questions is presented elsewhere.(Hu et al., 2003) The 
subjects reported their occupational physical activity according to the following three 
categories: light, moderate and active. The daily commuting return journey to work was 
grouped into three categories: (i) using motorized transportation, or not working outside home 
(0 minutes of walking or cycling); (ii) walking or bicycling 1 to 29 minutes; (iii) walking or 
bicycling for more than 30 minutes. Self-reported leisure time physical activity was classified 
into three categories: low, moderate and high. Since we found that moderate and high 
occupational, commuting or leisure time physical activity independently and significantly 
reduces risk of HF (data not shown), the groups were merged into three categories: (i) low was 
defined as subjects who reported light levels of occupational, commuting (<1 minute) and 
leisure time physical activity; (ii) moderate was defined as subjects who reported only one of 
the all three types of moderate to high physical activity; (iii) high was defined as subjects who 
reported two or three types of moderate to high physical activity. Participants were also 
classified as never, ex- and current-smokers based on their responses to the questionnaire. 
Current smokers were categorized into those participants who smoked <20, or ≥20 cigarettes 
per day. Since questions on alcohol consumption were different between the first 2 surveys 
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(1972 and 1977) and the latter surveys, the participants were categorized into abstainers and 
alcohol users. Data on the history of myocardial infarction or diabetes at baseline were 
obtained from the questionnaire and collected by hospital discharge or drug register. Data on 
the history of valvular heart disease at baseline were collected from the national hospital 
discharge register by record linkage.  
The participants were asked, “How many cups of coffee or tea do you drink daily (1 cup 
of coffee equals to 1 dL; one cup of tea equal to 2 dL)?”(Tuomilehto et al., 2004) Based on 
the validation study of the dietary questionnaire carried out in subgroups of the study 
population,(Paalanen et al., 2006) the correlations between the dietary questionnaire and 
food records for the amount of coffee consumed were 0.89 in men and 0.85 in women. 
Coffee consumption was categorized into six categories: 0 cup, 1-2 cups, 3-4 cups, 5-6 cups, 
7-9 cups and ≥10 cups per day. As only a few people drank tea, tea consumption was 
categorized into three categories: none, 1-2 cups, and ≥3 cups.  
At the survey site, specially trained research nurses measured participants’ height and 
weight by using the standardized WHO MONICA protocol.(Pajak et al., 1988) Height and 
weight were measured without shoes and with light clothing. The measurements of height 
were rounded to the nearest centimeter and weight to nearest 100 grams.(Pajak et al., 1988) 
Body mass index (BMI) was calculated by dividing weight in kilograms by the square of 
height in meters. Blood pressure was measured from the right arm after five minutes of sitting 
using a mercury sphygmomanometer in each survey. After blood pressure measurement, a 
venous blood specimen was taken. Total cholesterol was determined by using Lieberman 
Burchard method in 1972 and 1977 and by an enzymatic method (CHOD-PAP, Boehringer 
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MANNHEIM, Mannheim, Germany) since 1982. Because the enzymatic method gave 2.4% 
lower values than the Lieberman-Burchard method, the values measured in 1972 and 1977 
were corrected by this percentage.(Sundvall et al., 2007) All samples were analyzed in the 
same central laboratory at the National Public Health Institute. 
Prospective follow-up 
Follow-up information was from the Finnish Hospital Discharge Register and the 
National Social Insurance Institution’s Register on special reimbursement for HF drugs for 
non-fatal outcomes and the Finnish Death Register for fatal outcomes by record linkage using 
the personal identification numbers assigned to every citizen of Finland. The International 
Classification of Diseases (ICD) codes 427.00 and 427.10 (ICD-8), 428, 4029B (hypertensive 
heart disease with HF) and 4148A-X (ischemic HF with chronic CHD) (ICD-9), and I 50, 
I11.0 (hypertensive heart disease with HF), I13.0 and I13.2 (hypertensive heart and renal 
disease with HF) (ICD-10) were used to identify HF cases in the above-mentioned national 
databases. A HF diagnosis was made by the treating physicians, based on a clinical 
assessment, X-ray examination and, to various extents echocardiography. Follow-up of each 
cohort member continued until the date of the diagnosis of HF from Hospital Discharge 
Register, the National Social Insurance Institution’s Register or mortality, death from causes 
other than HF, or December 31, 2007. This method to ascertain HF cases in prospective 
epidemiological studies has been used in other Scandinavian countries, such as Sweden. The 
accuracy of the HF cases in the Swedish hospital discharge is found to be over 80% compared 
with the European Society of Cardiology (ESC) definition of HF.(Ingelsson et al., 2005a)  
 
47 
 
Statistical analyses 
Differences in risk factors at baseline based on different levels of coffee consumption 
were tested using General Linear Model after adjustment for age and study year. Cox 
proportional hazards regression models were used to analyze the association of coffee 
consumption with the risk of HF. Coffee consumption categories were included in the models 
as dummy and categorical variables, and the significance of the trend over different categories 
of coffee consumption was tested in the same models by giving an ordinal numeric value for 
each dummy variable. The proportional hazards assumption in the Cox model was assessed 
with graphical methods, and with models including time-by-covariate interactions.(Cox, 
1972) In general, all proportionality assumptions were appropriate. The analyses were first 
carried out adjusting for age and study year, and further adjusting for smoking, education, 
alcohol consumption, tea consumption, physical activity, BMI, systolic blood pressure, 
history of myocardial infarction, history of valvular heart disease, history of diabetes, and total 
cholesterol. To avoid a potential bias due to severe disease at baseline, additional analyses 
were carried out excluding the subjects who died during the first two years of follow-up 
(n=483). Statistical significance was considered to be P<0.05. Statistical package SPSS for 
Windows, version 17.0 (SPSS Inc, Chicago, III), was used for statistical analysis. 
3.3 Results  
During a mean follow-up of 19.2 years, 2020 men and 1807 women developed HF. 
General characteristics of the study population at baseline are presented by levels of coffee 
consumption in Table 7. After adjustment for age and study year, coffee consumption had a  
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Table 7. Baseline characteristics among men and women by volume of coffee consumption* 
 
Characteristics 
Daily coffee consumption, cups P value 
for trend 0 1-2 3-4 5-6 7-9 ≥10 
Men        
Participants, n 1887 3510 7042 8916 4127 3355  
Age, y 43.6(0.3) 45.7(0.2) 45.8(0.1) 45.6(0.1) 44.3(0.2) 43.0(0.2) <0.001 
BMI, kg/m
2
 26.0(0.1) 26.3(0.1) 26.4(0.0) 26.5(0.0) 26.4(0.0) 26.6(0.1) <0.001 
Systolic blood pressure, mmHg 141(0.1) 143(0.3) 143(0.2) 142(0.2) 142(0.3) 142(0.3) <0.001 
Diastolic blood pressure, mmHg 86(0.3) 88(0.2) 87(0.1) 87(0.1) 86(0.2) 86(0.2) <0.001 
Total cholesterol, mg/dL 224(1.0) 229(0.7) 234(0.5) 238(0.5) 241(0.7) 243 (0.8) <0.001 
Education, y 10.2(0.1) 10.3(0.1) 10.0(0.0) 9.3 (0.0) 9.0(0.1) 8.8(0.1) <0.001 
Low physical activity, % 8.9 8.1 7.2 7.6 7.3 10.0 <0.001 
Tea drinker, % 65.0 63.3 41.1 24.7 14.4 11.5 <0.001 
Alcohol drinker, % 55.2 72.5 69.1 66.6 63.9 60.0 <0.001 
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Table 7 continued 
Current smoker, % 22.7 29.3 33.7 42.8 50.4 64.6 <0.001 
History of myocardial infarction, % 3.2 3.7 4.2 3.7 2.4 2.8 <0.001 
History of diabetes, % 2.1 3.0 2.3 2.3 2.4 2.6 0.176 
History of valvular heart disease, % 0.2 0.2 0.2 0.1 0.0 0.1 0.341 
Women        
Participants, n 2015 4348 9777 9775 3287 1451  
Age, y 40.0(0.3) 44.5(0.2) 45.8(0.1) 45.9(0.1) 44.3(0.2) 43.2(0.3) <0.001 
BMI, kg/m
2
 25.8(0.1) 25.7(0.1) 25.9(0.0) 26.3(0.0) 26.6 (0.1) 26.9(0.1) <0.001 
Systolic blood pressure, mmHg 139(0.4) 138(0.3) 138(0.2) 139(0.2) 138(0.3) 138 (0.5) 0.200 
Diastolic blood pressure, mmHg 82(0.2) 83(0.2) 83(0.1) 83 (0.1) 83(0.2) 82(0.3) <0.001 
Total cholesterol, mg/dL 229(1.0) 228(0.7) 230(0.4) 233(0.4) 235 (0.8) 233(1.1) <0.001 
Education, y 10.5(0.1) 10.7(0.0) 10.3(0.0) 9.7(0.0) 9.3(0.1) 9.2(0.1) <0.001 
Low physical activity, % 13.6 10.8 9.1 8.5 9.1 11.8 <0.001 
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Table 7 continued 
Tea drinker, % 69.0 65.8 43.8 25.4 14.7 12.5 <0.001 
Alcohol drinker, % 29.6 43.0 41.0 37.8 36.6 36.8 <0.001 
Current smoker, % 5.3 10.7 15.2 20.9 25.1 43.4 <0.001 
History of myocardial infarction, % 1.5 1.4 0.9 0.8 0.6 1.1 0.001 
History of diabetes, % 2.3 2.2 1.8 1.7 2.1 1.7 0.267 
History of valvular heart disease, % 0.1 0.1 0.1 0.1 0.0 0.0 0.377 
*All data, except age, adjusted for age and study year. 
*Values represent mean (SE) or percentage. 
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Table 8. Hazard ratio for heart failure by categories of coffee consumption 
 Daily coffee consumption, cups P value 
for trend 0 1-2 3-4 5-6 7-9 ≥10 
Men        
  No. of cases 113 185 438 691 338 255  
  Person-years 32097 61573 126507 169558 82149 61938  
  Adjustment for age and study year 1.00 0.97 (0.76-1.24) 1.05 (0.85-1.30) 1.12 (0.91-1.38) 1.17 (0.94-1.47) 1.41 (1.13-1.78) 0.001 
  Multivariate adjustment* 1.00 0.91 (0.71-1.16) 0.88 (0.70-1.10) 0.91 (0.73-1.13) 0.96 (0.76-1.22) 1.02 (0.80-1.30) 0.485 
Women        
  No. of cases 84 149 514 681 257 122  
  Person-years 31833 74339 184786 212511 75168 29983  
  Adjustment for age and study year 1.00 0.73 (0.56-0.97) 0.76 (0.60-0.97) 0.74 (0.58-0.93) 0.88 (0.68-1.14) 1.12 (0.85-1.50) <0.001 
  Multivariate adjustment* 1.00 0.73 (0.56-0.97) 0.77 (0.60-0.98) 0.68 (0.53-0.88) 0.80 (0.61-1.04) 0.88 (0.65-1.19) 0.007 
*Adjusted for age, study year, education, cigarette smoking (never, past, and current smoking of 1-19 or ≥20 cigarettes/d), alcohol consumption 
(yes and no), physical activity, BMI, systolic blood pressure, total cholesterol, history of myocardial infarction, diabetes, valvular heart disease, 
and tea consumption.
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Table 9. Hazard ratio for heart failure by categories of tea consumption 
 Daily tea consumption, cups P value for trend 
0 1-2 ≥3 
Men     
  No. of participants 19,312 6,888 2,637  
  No. of cases 1, 472 379 169  
  Person-years 361,420 122,015 50,388  
  Adjustment for age and study year 1.00 0.85 (0.76-0.95) 0.80 (0.68-0.95) 0.002 
  Multivariate adjustment* 1.00 0.96 (0.85-1.08) 0.96 (0.81-1.15) 0.741 
Women     
  No. of participants 18,969 9,394 2,290  
  No. of cases 1, 268 413 126  
  Person-years 389,614 175,855 43,152  
  Adjustment for age and study year 1.00 0.84 (0.76-0.94) 0.99 (0.83-1.19) 0.011 
  Multivariate adjustment* 1.00 0.90 (0.80-1.01) 0.98 (0.81-1.20) 0.208 
* Adjusted for age, study year, education, cigarette smoking (never, past, and current smoking of 1-19 or  ≥20 cigarettes/d), alcohol consumption 
(yes and no), physical activity, BMI, systolic blood pressure, total cholesterol, history of myocardial infarction, diabetes, valvular heart disease, 
and coffee consumption. 
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direct association with BMI level and current smoking, and an inverse association with 
education level and tea consumption.  
In age and study year-adjusted analysis, we found a positive association between coffee 
consumption and the risk of HF for men (Table 8); however, when we further adjusted for 
other risk factors (BMI, smoking, education, alcohol consumption, tea consumption, physical 
activity, systolic blood pressure, history of myocardial infarction, history of valvular hear 
disease, history of diabetes, and total cholesterol), the positive association in men 
disappeared, which suggests that the age and study year-adjusted results were strongly 
confounded by other risk factors for HF. In women, a significant inverse association between 
low-to-moderate coffee consumption (1-6 cups/day) and the risk of HF was found in age and 
study year-adjusted analysis. Additional adjustment for other risk factors did not appreciably 
alter the results. The pooled multivariable-adjusted hazard ratios (HRs) across categories of 
coffee consumption were 1.00, 0.83 (95% confidence interval [CI] 0.69-1.00), 0.85 (95% CI 
0.72-1.00), 0.81 (95% CI 0.69-0.96), 0.90 (95% CI 0.76-1.08), and 0.98 (95% CI 0.81-1.18) 
(Ptrend=0.009). 
In age and study year-adjusted analysis, we found a negative association between tea 
consumption and the risk of HF for men and women (Ptrend=0.002 for men and Ptrend=0.011 
for women) (Table 9). After further adjustment for other risk factors, these inverse 
associations were no longer significant (all Ptrend>0.2). 
Stratification by age, smoking status, alcohol consumption, history of type 2 diabetes 
mellitus, and BMI gave similar results. 
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Exclusion of the participants who died during the first two years of follow-up did not 
appreciably change the results above. 
3.4 Discussion 
In this large population-based prospective study, we did not find any detrimental effect 
of coffee consumption on the risk of HF in either men or women. Actually, in women 
low-to-moderate amount of coffee drinking was associated with a reduced risk of HF.  
To the best of our knowledge, only two studies have assessed the association between 
coffee consumption and the risk of HF, and both studies included Swedish men.(Ahmed et 
al., 2009; Wilhelmsen et al., 2001) The results of the present study support the findings of 
prior work that coffee consumption is not significantly associated with the risk of HF in men. 
(Ahmed et al., 2009) Moreover, for the first time, the present study also included women and 
observed a decreased risk of HF in women with low-to-moderate coffee consumption (1-6 
cups daily). According to international statistics, the Finnish population has the highest per 
capita coffee consumption in the world, at 11.4 kg/year.(World Resources Institute) Research 
into the potential health effects of coffee in this population is therefore of particular interest.  
Although the mechanism behind the association between coffee consumption and the 
risk of HF among women is incompletely understood, several putative mechanisms have 
been proposed. Because HF and CHD share risk factors such as: hypertension, diabetes, 
obesity, and smoking, CHD is regarded as a more common etiology in HF than ever 
before.(Fox KF, 1998; Wilhelmsen et al., 2001) In our study population, it has been 
previously shown that coffee drinking was associated with decreased CHD 
mortality(Kleemola et al., 2000) and the incidence of type 2 diabetes,(Tuomilehto et al., 
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2004) whereas the lowest incidence of hypertension was found in people who did not drink 
coffee but no gradient in hypertension incidence with increasing coffee drinking was 
seen.(Hu et al., 2007b) Also, Wu et al.(Wu et al., 2009) reported that their meta-analysis of 
21 prospective cohort studies on the association between coffee consumption and the risk of 
CHD did not support the hypothesis that coffee consumption increases the long-term risk of 
CHD, and habitual moderate coffee drinking was associated with a lower risk of CHD in 
women.(Wu et al., 2009) Their findings on the relationship between coffee consumption and 
the risk of CHD are similar with our findings about the association between coffee 
consumption and the risk of HF. Therefore, the effect of coffee consumption on HF may be 
partly mediated by its effect on other risk factors for CHD. In our study, the adjustment for 
the history of myocardial infarction and other CHD risk factors attenuated the association 
between coffee consumption and HF risk, and the association still remained significant 
among women but not among men.  
The reason for the gender difference we have observed in the association between coffee 
consumption and HF risks is unclear. This finding is however in keeping with the finding of 
the observation regarding CHD mortality based on these same data: inverse association in 
women while no association in men.(Kleemola et al., 2000) Many epidemiologic studies 
have demonstrated that it is more likely for smokers than non-smokers to have more 
unhealthy lifestyle habits (e.g., physical inactivity, alcohol abuse).(Aasland and Nylenna, 
1997) In the present study, coffee consumption was directly associated with smoking, and 
the prevalence of smoking was much higher among men than women. Although smoking 
was adjusted in our study, not all smoking-related unhealthy lifestyle habits were controlled. 
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Therefore, one explanation involved is that the difference in the prevalence of smoking 
between men and women and smoking related unhealthy lifestyle habits may be partially 
responsible for the observed gender difference in the association between coffee 
consumption and HF risk.(Wu et al., 2009) 
There are mainly three categories of functional compounds in coffee: caffeine, 
antioxidants, and trace elements. Caffeine, a major component of coffee, prevents 
adenosine’s negative inotropic effect as an adenosine-receptor antagonist(Van Soeren and 
Graham, 1998) and increases the sensitivity of the myofilaments to calcium.(Hess and Wier, 
1984) Also, caffeine decreases insulin sensitivity(Keijzers et al., 2002) and increases serum 
homocysteine levels(Verhoef et al., 2002) and blood pressure.(Noordzij et al., 2005) In 
addition, caffeine stimulates free fatty acid release from peripheral tissues.(Ryu et al., 2001) 
On the other hand, antioxidants, obtained from coffee, like chlorogenic acid, phenolic 
compounds, flavonoids, melanoidins, and various lipid-soluble compounds such as furans, 
pyrroles, and maltol have beneficial antioxidant effects and might improve insulin 
sensitivity.(Arnlov et al., 2004) Trace elements in coffee such as potassium, niacin, and 
magnesium have beneficial effects on glucose and insulin metabolism,(Natella et al., 2002) 
improve insulin sensitivity,(Arnlov et al., 2004) decrease low-grade 
inflammation,(Lopez-Garcia et al., 2006) and lower diabetes risk.(van Dam and Hu, 2005) In 
our prior work, we observed an inverse and graded association between coffee consumption 
and type 2 diabetes,(Tuomilehto et al., 2004) which is recognized as one of the risk factors of 
HF.  
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There are several strengths and limitations in our study. First, a large number of both 
men and women from a homogeneous population participated in the study. Second, the mean 
follow-up was sufficiently long to ascertain a large number of HF endpoint events. We also 
carried out additional analyses excluding the subjects who died during the first two years of 
follow-up to avoid a potential bias due to a possible change in coffee consumption with 
severe disease. A limitation of our study was that we used self-report data on coffee intake 
only at baseline. However, the misclassification of exposure during the follow-up is most 
probably not systematically related to the outcome. Second, we did not assess the effect of 
caffeine on the risk of coffee consumption since we did not have available information about 
other main sources of caffeine, i.e. the consumption of cola beverage and chocolate. Third, 
even though our analyses were adjusted for physical activity, smoking, tea, and alcohol 
intake, residual confounding due to the measurement error in the assessment of confounding 
factors, unmeasured factors such as diet, cannot be excluded. In general, the associations 
between coffee consumption and HF risk were not influenced substantially or systematically. 
Finally, ascertainment of HF status was based on the National Hospital Discharge Registry, 
the National Social Insurance Institution’s Register on special reimbursement for HF drugs, 
and Causes of Death Register. This diagnosis method has been used in other Scandinavian 
countries, such as Finland and Sweden.(Ingelsson et al., 2005a; Wang et al.) The accuracy of 
the HF cases in the Swedish hospital discharge is found to be over 80% based on the ESC 
definition.(Ingelsson et al., 2005a) Although accuracy of clinical HF diagnosis in our cohort 
is likely to be high, some diagnostic errors are inevitable. However, the misdiagnosis is most 
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likely to be independent of the exposure status and therefore tends to attenuate the 
underlying associations rather than cause spurious associations.  
In conclusion, our study confirms that coffee consumption does not increase the risk of 
HF in Finnish men and women who have the highest consumption of coffee in the world. In 
women, we observed an inverse association between low-to-moderate coffee consumption 
and the risk of HF.  
 
 
59 
 
CHAPTER 4. LIFESTYLE FACTORS IN RELATION TO HEART FAILURE 
AMONG FINNISH MEN AND WOMEN
4
 
4.1. Introduction 
Heart failure (HF) poses a great threat to people around the world with its high prevalence, 
poor clinical outcomes, and large health-care costs.(Krum and Abraham, 2009; Sharp and 
Doughty, 1998) Except for the medical treatments for the cardiovascular risk factors of HF, 
modifiable lifestyle factors can also affect the development of HF. Compared with medical 
intervention, the prevention of HF through lifestyle approaches is free of side effect. 
Modifiable lifestyle factors like smoking,(Djousse et al., 2009; Eriksson et al., 1989a; He et al., 
2001; Hoffman et al., 1994; Wilhelmsen et al., 2001) physical activity,(Djousse et al., 2009; 
Hu et al., 2010b; Kenchaiah et al., 2009; Wang et al., 2010b) adiposity,(Djousse et al., 2009; 
Hu et al., 2010b; Kenchaiah et al., 2002; Kenchaiah et al., 2009; Levitan et al., 2009a) alcohol 
consumption,(Abramson et al., 2001; Bryson et al., 2006; Djousse et al., 2009; Djousse and 
Gaziano, 2007a; Walsh et al., 2002) and dietary intake,(Djousse et al., 2009; Wang et al., 
2011b) have been shown to influence the risk of HF in several studies. In the only 
epidemiological investigation related to the joint effect of these modifiable lifestyle factors on 
HF risk,(Djousse et al., 2009) engaging in healthy lifestyle factors was associated with the 
remaining lifetime risk of HF in men. However, it is unclear if this observed finding is 
generalizable to other populations and to both sexes. In order to gain a more comprehensive 
understanding of the effect of engaging in lifestyle factors on HF risk, we aim to examine the 
                                                   
4 This chapter originally appeared as Yujie Wang, Jaakko Tuomilehto, Pekka Jousilahti, Riitta Antikainen, Markku 
Mähönen, Peter T. Katzmarzyk, and Gang Hu. Lifestyle factors in relation to heart failure among Finnish men and women. 
Circulation: heart failure, 4(5), 607-612, 2011. Reprinted by permission of Wolters Kluwer Health. 
http://circheartfailure.ahajournals.org/content/4/5/607 
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single and combined effects of smoking, body mass index (BMI), physical activity, and 
vegetable intake on HF risk in a large prospective cohort of Finnish men and women.  
4.2 Methods 
Subjects 
Five independent cross-sectional population-based health examination surveys (FINRISK) 
were carried out in six geographic areas of Finland in 1982, 1987, 1992, 1997 and 
2002.(Vartiainen et al.) The original random sample was stratified by area, gender and 10-year 
age group according to the World Health Organization (WHO) MONICA (MONItoring trends 
and determinants of CArdiovascular disease) protocol.(Pajak et al., 1988) The participation 
rate varied by year from 65% to 88%.(Vartiainen et al.) The subjects included in the five 
surveys were 25 to 64 years of age, and the 1997 and 2002 surveys also included subjects aged 
65 to 74 years. Subjects who participated in more than one survey were included only in the 
first survey cohort. The total sample size of the five surveys was 38,737. The final sample 
comprised 18,346 men and 19,729 women after excluding the participants with a history of HF 
(n=457) at baseline, and the participants with incomplete data on any variables required for 
this analysis (n=205). The participants gave an informed consent (verbal from 1982 to 1992 
and written in 1997 and 2002). These surveys were conducted according to the ethical rules of 
the National Public Health Institute, and the investigations were performed in accordance with 
the Declaration of Helsinki.  
Baseline measurements 
A self-administered questionnaire was mailed to the participants to be completed at home 
and returned to the survey site. The questionnaire included questions on medical history, 
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socioeconomic factors, physical activity, smoking habits, dietary intake, and alcohol 
consumption. Education level, measured as the total number of school years, was divided into 
birth cohort-specific tertiles. Data on the history of myocardial infarction or diabetes mellitus 
at baseline were obtained from the questionnaire and collected by hospital discharge diagnosis 
or drug register. Data on the use of antihypertensive agents at baseline were obtained from the 
questionnaire and drug register. Data on the history of valvular heart disease at baseline were 
collected by hospital discharge register.(Hu et al., 2010b; Hu et al., 2003; Wang et al., 2010b; 
Wang et al., 2011b)  
A detailed description of the questions on occupational and leisure-time physical activity 
has been presented elsewhere.(Hu et al., 2003; Wang et al., 2010b) Since we found that 
moderate and high occupational or leisure time physical activity independently and 
significantly reduces risk of HF,(Hu et al., 2010b; Wang et al., 2010b) the groups were merged 
into three categories: “low” when subjects reported light levels of both occupational and 
leisure time physical activity; “moderate” when subjects reported moderate or high level of 
either occupational or leisure time physical activity; and “high” when subjects reported 
moderate or high level of both occupational and leisure time physical activity. Participants 
were classified as never, ex- and current-smokers based on their responses to the questionnaire. 
Alcohol consumption was categorized into four groups: none, 0.1-35, 35.1-70, and >70 g per 
week. The frequency of consumption of vegetables and fruits over the last week (<1 
time/week, 1-2 times/week, 3-6 times/week, ≥7 times/week) were also inquired.(Hu et al., 
2007d)  
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At the survey site, specially trained research nurses measured participants’ height and 
weight by using the standardized WHO MONICA protocol.(Pajak et al., 1988) Height and 
weight were measured without shoes and with light clothing. The measurements of height 
were rounded to the nearest centimeter and weight to nearest 100 grams.(Pajak et al., 1988) 
BMI was calculated as weight in kilograms divided by the square of height in meters. Blood 
pressure was measured from the right arm after five minutes of sitting using a mercury 
sphygmomanometer in each survey. After blood pressure measurement, a venous blood 
specimen was taken. Total cholesterol was determined by an enzymatic method (CHOD-PAP, 
Boehringer MANNHEIM, Mannheim, Germany). All samples were analyzed in the same 
central laboratory at the National Public Health Institute. 
Prospective follow-up 
Follow-up information was from the Finnish Hospital Discharge Register and the 
National Social Insurance Institution’s Register on special reimbursement for HF drugs for 
non-fatal outcomes and the Finnish Causes of Death Register for fatal outcomes by record 
linkage using the personal identification numbers assigned to every citizen of Finland. The 
International Classification of Diseases (ICD) codes 427.00 and 427.10 (ICD-8), 428, 4029B 
(hypertensive heart disease with HF) and 4148A-X (ischemic HF with chronic coronary heart 
disease [CHD]) (ICD-9), and I 50, I11.0 (hypertensive heart disease with HF), I13.0 and I13.2 
(hypertensive heart and renal disease with HF) (ICD-10) were used to identify HF cases in the 
above-mentioned national databases. A HF diagnosis was made by the treating physicians, 
based on a clinical assessment and examinations as considered relevant by the clinician in 
charge of treatment. Follow-up of each cohort member continued until the date of the 
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diagnosis of HF from the Hospital Discharge Register, Causes of death register or from the 
National Social Insurance Institution’s Drug reimbursement Register or death resulting from 
causes other than HF, or December 31, 2007. This method to ascertain HF cases in prospective 
epidemiological studies has been used in Scandinavian countries, such as Sweden and 
Finland.(Ingelsson et al., 2005a; Levitan et al., 2009a; Wang et al., 2010a) A study from 
Sweden found the positive predictive value of HF diagnosis to be 82% (false positive rate 
18%).(Ingelsson et al., 2005a) Another study from Finland also found the specificity of the 
HF diagnoses to be acceptable for the epidemiological study.(Wang et al., 2010a)  
Statistical analyses 
Cox proportional hazards regression was used to calculate the hazard ratio (HR) and 95% 
confidence intervals (CIs) for categories of each of the 6 modifiable lifestyle factor (smoking 
[never, ever, and current], BMI [normal weight:<25 kg/m
2
, overweight: 25-29.9 kg/m
2
, and 
obese: ≥30 kg/m2], physical activity [low, moderate, and high], vegetable consumption [<1, 
1-2, 3-6, and ≥7 times per week], fruit consumption [<1, 1-2, 3-6, and ≥7 times per week], and 
alcohol consumption [none, 0.1-35, 35.1-70, and >70 g per week]).  
Next, each lifestyle factor was dichotomized as unhealthy vs healthy: smoking (current vs 
never or ever), BMI (≥25 vs <25 kg/m2), physical activity (low vs moderate or high), and 
vegetable consumption (≤2 vs ≥3 times per week). Fruit consumption and alcohol 
consumption were dropped out of the analyses because no significant associations with HF 
risk were found. Given that healthy lifestyle factors were defined as never or ever smoking, 
BMI <25 kg/m
2
, moderate or high levels of physical activity, and consumption of vegetable ≥3 
times per week, each person could have a minimum of 0 and maximum of 4 healthy lifestyle 
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factors. Differences in the general characteristics of study subjects who had 0, 1, 2, 3 or 4 
healthy lifestyle factors were tested using General Linear Models after adjustment for age and 
study year. The number of healthy lifestyle factors was included in the Cox proportional 
hazards regression models as dummy and categorical variables, and the significance of the 
trend over different categories was tested in the same models by giving an ordinal numeric 
value for each dummy variable. The proportional hazards assumption in the Cox model was 
assessed with graphical methods, and with models including time-by-covariate 
interactions.(Cox, 1972) In general, all proportionality assumptions were appropriate.  
All the above analyses were first carried out adjusting for age and study year, and further 
for education, systolic blood pressure, total cholesterol, and histories of myocardial 
infarction, valvular heart disease, diabetes, and using antihypertensive drugs. To avoid a 
potential bias due to severe disease at baseline, additional analyses were carried out excluding 
the subjects who died during the first two years of follow-up (n=290). Statistical significance 
was considered to be P<0.05. All the above statistical analyses were performed with PASW 
for Windows, version 18.0 (SPSS Inc, Chicago, III).  
To estimate the proportion of new HF cases occurring in this population that 
hypothetically could have been prevented if all subjects had been in the healthy lifestyle group, 
while the distribution of other modifiable and non-modifiable risk factors is unchanged, the 
partial population attributable risk percent (PAR%) (Spiegelman et al., 2007) and 95% CI 
were calculated by using SAS for Windows, version 9.12 (SAS Institute, Cary, NC).  
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4.3 Results  
During a median follow-up of 14.1 years (interquartile range 5.9-20.9 years), 638 men and 
445 women developed HF. General characteristics of the study population at baseline are 
presented by the number of healthy lifestyle factors in Table 10.  
Except for fruit consumption and alcohol consumption, the other individual components 
of the lifestyle factors were independently and significantly associated with the risk of HF 
when they were simultaneously entered into the multivariable model (Table 11). The most 
important risk factor for HF was smoking status; the HR of HF was 1.86 (95% CI 1.51-2.30) 
for men and 2.09 (95% CI 1.59-2.74) for women who were current smoker, as compared with 
subjects who never smoked. Overweight or obesity was also associated with a significantly 
increased HF risk, while engagement in moderate-to-high levels of physical activity, the 
consumption of vegetable more than three times per week were associated with a significantly 
decreased HF risk.  
In both age and study year-adjusted analysis and the multivariable-adjusted (age, study 
year, education, systolic blood pressure, total cholesterol, and histories of myocardial 
infarction, valvular heart disease, diabetes, and using antihypertensive drugs) analysis, a 
dose-response relationship between the combinations of the 4 healthy lifestyle factors 
(physical activity, smoking, BMI, and vegetable consumption) and the hazard ratios of HF was 
observed (Table 12). The partial PAR% associated with engaging in any 3 or 4 of the 
healthy lifestyle indicators were 45.6% (95% CI 36.5% - 53.8%) and 53.6% (95% CI 31.3% - 
70.2%), respectively, suggesting that 45.6% or 54.1% of new HF cases occurring in this 
population could have been prevented if all subjects had any 3 or 4 of the healthy lifestyle  
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Table 10. General characteristics of study at baseline* 
 No. of healthy lifestyle factors†  
0 1 2 3 4 P for trend 
Men        
No. of subjects  1,473  5,267 6,633 3,969 1,004  
Age at baseline (yrs) 47.5 (11.7) 48.7 (12.5) 47.2 (12.5) 44.3 (11.8) 41.4 (10.6) <0.001 
Body mass index (kg/m2) 29.1 (3.4) 27.8 (4.0) 26.9 (3.8) 25.3 (3.4) 23.2 (1.4) <0.001 
Current smoker (%) 100 53.8 28.3 11.5 0.0 <0.001 
Moderate or high physical activity (%) 0.0 16.7 41.8 70.2 100 <0.001 
Vegetable consumption ≥3 time/week (%) 0.0 18.5 55.8 82.8 100 <0.001 
Alcohol consumption (g/week) 107 (154) 89 (146) 77 (113) 67 (92) 56 (70) <0.001 
Diastolic blood pressure (mm Hg) 87 (12) 86 (12) 85 (12) 83 (11) 80 (11) <0.001 
Systolic blood pressure (mm Hg) 145 (19) 143 (19) 141 (19) 138 (18) 135 (17) <0.001 
Serum cholesterol (mmol/l) 6.13 (1.17) 6.00 (1.18) 5.81 (1.15) 5.66 (1.13) 5.46 (0.99) <0.001 
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Table 10 continued 
Education (yrs) 9.3 (3.3) 9.7 (3.8) 10.7 (4.0) 11.5 (4.0) 11.8 (3.7) <0.001 
History of myocardial infarction (%) 5.6 4.8 3.8 2.9 3.1 <0.001 
History of valvular heart disease (%) 0.1 0.2 0.2 0.2 0.2 0.767 
History of diabetes (%) 3.1 3.2 2.8 2.5 1.9 0.124 
History of using anti-hypertensive drugs (%) 12.8 13.7 12.8 8.5 4.1 <0.001 
Women        
No. of subjects 500 3,573 7,189 6,227 2,240  
Age at baseline (yrs) 44.9 (12.0) 48.8 (12.6) 47.8 (12.6) 44.0 (11.4) 41.0 (9.8) <0.001 
Body mass index (kg/m2) 29.9 (4.3) 28.9 (5.2) 27.1 (4.9) 24.5 (4.0) 22.4 (1.7) <0.001 
Current smoker (%) 100.0 41.5 21.5 8.9 0 <0.001 
Moderate or high physical activity (%) 0.0 5.3 19.9 52.7 100.0 <0.001 
Vegetable consumption ≥3 time/week (%) 0.0 19.5 67.8 89.0 100.0 <0.001 
Alcohol consumption (g) 40 (65) 25 (51) 26 (50) 25 (41) 23 (36) <0.001 
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Table 10 continued 
Diastolic blood pressure (mm Hg) 83 (12) 82 (11) 81 (11) 79 (11) 71 (10) <0.001 
Systolic blood pressure (mm Hg) 137 (20) 140 (22) 137 (21) 132 (20) 128 (17) <0.001 
Serum cholesterol (mmol/l) 5.94 (1.25) 5.99 (1.26) 5.81 (1.22) 5.56 (1.13) 5.35 (1.03) <0.001 
Education (yrs) 9.8 (3.1) 9.5 (3.6) 10.7 (3.9) 12.0 (3.9) 12.7 (3.6) <0.001 
History of myocardial infarction (%) 1.9 2.0 1.0 0.6 0.6 <0.001 
History of valvular heart disease (%) 0.2 0.1 0.1 0.1 0.1 0.872 
History of diabetes (%) 2.5 2.7 2.6 1.6 1.1 <0.001 
History of using anti-hypertensive drugs (%) 12.0 15.6 14.1 7.6 3.2 <0.001 
*Values are given as mean (SD) when appropriate.  
†Four modifiable lifestyle factors included smoking, body mass index, physical activity, and vegetable consumption. 
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Table 11. Hazard ratios of heart failure according to lifestyle factors 
 
 
Lifestyle factors 
Men P for 
trend 
Women P for 
trend No. of 
cases 
Person-y
rs 
Multivariable adjustment 
HR (95% CI)* † 
No. of 
cases 
Person-
yrs 
Multivariable adjustment 
HR (95% CI)* † 
Physical activity    0.006    0.009 
    Light 128 27,863 1.00  129 44,435 1.00  
    Moderate 334 118,082 0.79 (0.64-0.97)  229 138,989 0.87 (0.70-1.08)  
    High 176 115,186 0.67 (0.53-0.86)  87 109,288 0.64 (0.48-0.86)  
Smoking status     <0.001    <0.001 
    Never  153 98,111 1.00  347 201,982 1.00  
    Ever 213 67,484 1.06 (0.86-1.31)  25 32,189 1.02 (0.68-1.55)  
    Current 272 95,537 1.86 (1.51-2.30)  73 58,542 2.09 (1.59-2.74)  
Alcohol consumption (g/week)         
    0 272 94,275 1.00 0.225 346 170,956 1.00 0.899 
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Table 11 continued 
   0.1-35 75 34,306 0.91 (0.70-1.18)  54 54,170 0.90 (0.67-1.21)  
   35.1-70 92 40,378 1.00 (0.79-1.27)  30 38,268 1.01 (0.68-1.50)  
   >70 199 92,173 1.17 (0.96-1.42)  15 29,318 0.92 (0.53-1.57)  
Body mass index (kg/m2)    <0.001    <0.001 
    <25 142 95,701 1.00  97 145,836 1.00  
    25-29.9 293 122,376 1.15 (0.93-1.41)  155 95,847 1.21 (0.93-1.57)  
    ≥30 203 43,055 1.75 (1.40-2.20)  193 51,030 2.06 (1.59-2.67)  
Fruit consumption (time/week)    0.471    0.799 
    <1  109 36,062 1.00  48 18,735 1.00  
    1-2  261 99,472 1.14 (0.91-1.44)  133 71,441 0.89 (0.63-1.24)  
   3-6 153 74,523 1.00 (0.77-1.30)  129 89,447 0.92 (0.65-1.29)  
    ≥7 115 51,074 1.11 (0.83-1.47)  135 113,090 0.85 (0.60-1.20)  
Vegetable consumption (time/week)    0.047    0.153 
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Table 11 continued 
    <1  162 41,126 1.00  74 20,714 1.00  
    1-2  258 95,067 0.88 (0.72-1.08)  162 80,296 0.89 (0.67-1.18)  
   3-6 148 81,316 0.74 (0.58-0.94)  123 109,376 0.73 (0.54-0.99)  
    ≥7 70 43,623 0.70 (0.51-0.96)  86 82,328 0.93 (0.60-1.31)  
*HR = hazard ratio; CI = confidence interval. 
†Adjusted for age, study year, smoking, vegetable consumption, fruit consumption, education, alcohol consumption, history of myocardial 
infarction, history of valvular heart disease, history of diabetes, history of using anti-hypertensive drugs, BMI, systolic blood pressure, and total 
cholesterol, other than the variable in the analytic model.
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Table 12. Hazard ratios of heart failure according to number of healthy lifestyle factors restricted to adiposity, smoking, physical activity, and 
vegetable consumption 
 men women 
No. of healthy 
lifestyle factors 
No. of cases     Person-yrs Age and study 
years adjusted HR 
(95% CI) * 
Multivariable 
adjustment HR 
(95% CI) † 
No. of cases     
Person-yrs 
Age and study 
years adjusted HR 
(95% CI) 
Multivariable 
adjustment HR 
(95% CI)
 † 
0 97 19,441 1.00 1.00 20 7,009 1.00 1.00 
1 271 72,805 0.64 (0.50-0.80) 0.68 (0.54-0.86) 168 53,030 0.59 (0.37-0.94) 0.53 (0.33-0.85) 
2 191 93,954 0.39 (0.31-0.50) 0.44 (0.35-0.57) 185 104,487 0.43(0.27-0.69) 0.42 (0.27-0.67) 
3 67 59,020 0.28 (0.20-0.38) 0.33 (0.24-0.45) 61 93,757 0.24 (0.14-0.39) 0.24 (0.14-0.40) 
4 12 15,912 0.25 (0.14-0.46) 0.30 (0.16-0.54) 11 34,431 0.18 (0.08-0.37) 0.19 (0.09-0.40) 
P for trend   <0.001 <0.001   <0.001 <0.001 
*HR = hazard ratio; CI = confidence interval. 
†Adjusting for age, study year, education, history of myocardial infarction, history of valvular heart disease, history of diabetes, history of using 
anti-hypertensive drugs, systolic blood pressure, and total cholesterol. 
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indicators. However, since PAR% assumes the lifestyle factors are causal, it should be 
interpreted with caution. 
Exclusion of the participants who died during the first two years of follow-up did not 
appreciably change the results above. 
4.4 Discussion 
In the present study, we observed that maintaining a BMI ≤25, consuming vegetable ≥3 
times a week, abstaining from smoking and engaging in moderate or high level of physical 
activity were individually and jointly associated with a decreased risk of HF among both men 
and women. Furthermore, the dose-response relationship between the number of healthy 
lifestyle factors one engaged in and HF risk suggested that the closer one was engaging in a 
healthy lifestyle, the further the risk of HF was reduced. 
Smoking, which was identified as the most powerful predictor of incident HF in the 
current cohort, was first shown to be the major independent risk factor of HF in a study 
(Eriksson et al., 1989a) conducted on 973 men born in 1913 in Gothenburg, Sweden. The 
authors found that smoking at age 50 was associated with a 60% higher risk of Congestive HF 
(RR, 1.6; 95%, 1.2-3.2), and this relationship was independent of hypertension and other 
important risk factors of Congestive HF. The finding has been confirmed by several other 
studies conducted on different population.(He et al., 2001; Hoffman et al., 1994; Wilhelmsen 
et al., 2001) Based on the evidence revealing the positive association between smoking and HF, 
the European Society of Cardiology, American College of Cardiology, and American Heart 
Association identified smoking as one of the risk factors as well as one of the targets of 
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prevention and management of HF in their guidelines.(Dickstein et al., 2008; Hunt et al., 2005; 
Schocken et al., 2008b)  
The relation of physical activity(He et al., 2001; Hu et al., 2010b; Kenchaiah et al., 2009; 
Wang et al., 2010b) and obesity(Bahrami et al., 2008; Chen et al., 1999; He et al., 2001; Hu et 
al.; Ingelsson et al., 2005b; Ingelsson et al., 2005c; Kenchaiah et al., 2002; Kenchaiah et al., 
2009; Levitan et al., 2009a; Loehr et al., 2009) to HF has been studied extensively. The results 
from these prospective studies consistently indicate that regular physical activity reduces the 
risk of HF, while both general obesity and abdominal obesity increase the risk of HF. 
Furthermore, research (Hu et al., 2010b; Kenchaiah et al., 2009) related to the joint effect of 
obesity and physical activity on HF risk indicates that lean and active individuals had the 
lowest HF risk. Therefore, preventing of HF by maintaining optimal weight and involving in 
regular physical activity may be promising in reducing the public health burden of HF 
worldwide.  
Although dietary pattern and food choices have been associated with risk factors for HF 
such as hypertension, CHD and type 2 diabetes, the role of diet on HF has not been studied 
adequately to date. Djoussé ea al (Djousse et al., 2009; Djousse and Gaziano, 2007b) have 
done extensive work to evaluate the associations between dietary factors on the risk of HF by 
using the data from the Physicians’ Health Study: their studies showed that fruit and vegetable 
consumption (Djousse et al., 2009) and whole-grain breakfast cereals consumption (Dhingra 
et al., 2010) were associated with a reduced risk of HF. The Swedish Mammography Cohort 
showed that diets consistent with the DASH diet, a diet features high intake of fruits, 
vegetables, low-fat dairy products, and whole grains, were associated with a decreased risk of 
75 
 
HF.(Levitan et al., 2009b) In the current study, fruit consumption was not associated with the 
risk of HF which is different from the findings from the study conducted by Djoussé ea 
al.(Djousse et al., 2009) The inconsistency might be partly explained by the different 
questionnaires used to assess fruit consumption, and the differences in the dietary habits 
between the Finish population and Americans. All these studies together with the current 
study suggest that the prevention of HF through dietary approaches should be stressed. 
The studies that have addressed alcohol consumption and the risk of HF have yielded 
inconsistent results.(Abramson et al., 2001; Bryson et al., 2006; Djousse et al., 2009; Djousse 
and Gaziano, 2007a; Walsh et al., 2002) Like us, Bryson et al(Bryson et al., 2006) did not find 
a significant association between alcohol consumption and the risk of HF. In contrast, several 
studies(Abramson et al., 2001; Bryson et al., 2006; Djousse et al., 2009; Walsh et al., 2002) 
showed that moderate alcohol consumption was associated with a reduced risk of HF, whereas 
alcohol abuse was associated with a higher risk of HF.(Wilhelmsen et al., 2001) The 
discrepancy among these findings may be partly explained by the different assessment of 
alcohol consumption, and the age and race difference between the study samples of these 
studies. In order to establish the association between alcohol consumption and HF and make 
appropriate recommendations to the general public especially those at high risk for HF, further 
studies are needed.     
To the best of our knowledge, the only study(Djousse et al., 2009) addressing the 
association between the joint effect of modifiable lifestyle factors on HF risk was conducted 
among male physicians who are more aware of the consequences of unhealthy lifestyle than 
the general public. The results of the present study support their finding that engaging in 
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healthy lifestyle factors is associated with a lower HF risk in men. Moreover, for the first time, 
the present study demonstrated a similar association in women. Although each of these 4 
modifiable lifestyle factors has been shown to be independently associated with the risk of HF 
in various studies, the general public does not have enough awareness of these associations, 
and the prevalence of unhealthy lifestyle continues to be high. Large social and 
community-based lifestyle intervention may help to prevent and manage HF. 
There are several strengths and limitations in our study. First, a major strength of the study 
is the large number of both men and women from a homogeneous population who participated 
in the study. Second, the follow-up time was sufficiently long to ascertain a large number of 
HF endpoint events. Finally, we also carried out additional analyses excluding the subjects 
who died during the first two years of follow-up to avoid a potential bias due to a severe 
disease at baseline. A limitation of our study is that information on self-reported physical 
activity, smoking habits, vegetable and alcohol consumptions was recorded only once at 
baseline. We have no data on possible changes in the lifestyle factors during the follow-up. 
However, the misclassification of the levels of these lifestyle factors during the follow-up is 
most probably not systematically related to the outcome, but may weaken the observed 
association. Ascertainment of HF status was based on the National Hospital Discharge 
Registry, the National Social Insurance Institution’s Register on special reimbursement for HF 
drugs, and Causes of Death Register. These data are primarily collected for administrative 
purposes and not for a scientific study. There are guidelines for assigning diagnoses in these 
register and established quality control procedures, but the diagnoses may vary over time and 
between the hospitals. This method for ascertaining the HF outcome has, however, been 
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successfully used in prior studies in Scandinavian countries, such as Finland and Swede.(Hu et 
al., 2010b; Ingelsson et al., 2005a; Levitan et al., 2009a; Wang et al., 2010a; Wang et al., 
2010b; Wang et al., 2011b) Also, we cannot completely either exclude the effects of residual 
confounding due to measurement error in the assessment of confounding factors, or some 
unmeasured dietary factors. An additional limitation is the use of the healthy lifestyle point 
system. Each healthy lifestyle factor was weighted the same which implies that each is 
equally important, though the results indicated that smoking was the strongest risk factor for 
HF. This may lead to heterogeneous people being in the same category.  
In conclusion, there was a graded inverse association between the number of healthy 
lifestyle factors and the risk of HF in Finnish men and women. Therefore, in order to reduce 
the incidence of HF, more efforts should be put into promoting healthy lifestyles and their 
associated health benefits. 
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CHAPTER 5. HEALTHY LIFESTYLE STATUS, ANTIHYPERTENSIVE 
TREATMENT AND THE RISK OF HEART FALIURE AMONG FINNISH MEN AND 
WOMEN
5
 
5.1 Introduction 
Heart failure (HF), which lead to 3,434,000 clinical visits in 2007 in the U.S,(Schappert 
and Rechtsteiner, 2011) has become a major health problem. According to the American 
Heart Association (AHA),(Roger et al., 2011) 1 in 9 death certificates (277,193 deaths) in the 
U.S. included heart failure as a contributing cause of death in 2007.  
Hypertension is one of the major risk factors of HF: 75% of HF cases have antecedent 
hypertension.(Lloyd-Jones et al., 2002) However, there is little information on the risk of HF 
in treated hypertensive people, controlled or uncontrolled for their blood pressure compared 
with normotensive individuals followed over a long period. Also, data from our recent 
publication(Wang et al., 2011a) demonstrated a graded inverse association between number of 
healthy lifestyle traits (maintaining a body mass index [BMI] ≤25, consuming vegetables ≥3 
times a week, abstaining from smoking and engaging in moderate or high level of physical 
activity) and the risk of HF in the Finnish general population.  
Ideal cardiovascular health is now defined by the presence of the traditional health 
factors (untreated total cholesterol <200 mg/dL, untreated blood pressure <120/<80 mm Hg, 
and fasting blood glucose <100 mg/dL) as well as ideal health behavioral factors 
(nonsmoking, BMI <25 kg/m
2
, physical activity at goal levels, and pursuit of a diet consistent 
with current guideline recommendations) according to a recent special report of the 
                                                   
5 This chapter originally appeared as Yujie Wang, Jaakko Tuomilehto, Pekka Jousilahti, Riitta Antikainen, Markku 
Mähönen, Peter T. Katzmarzyk, and Gang Hu. Healthy lifestyle status, antihypertensive treatment and the risk of heart 
failure among Finnish men and women. Accepted by Journal of Hypertension on June 10, 2013. Reprinted by permission of 
Wolters Kluwer Health.   
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AHA.(Lloyd-Jones et al., 2010) One study has demonstrated that a healthy lifestyle 
significantly decreases stroke risk  in different strata of hypertension status and 
antihypertensive drug treatments.(Zhang et al., 2012) However, based on the available 
evidence, it is unclear that which is more effective in preventing HF in hypertensive people: 
lifestyle intervention or antihypertensive drug treatment. Therefore, this study aimed to 
investigate 1) whether there are differences in HF risk among hypertensive men and women 
using antihypertensive drug treatment at baseline versus those engaging in a healthy lifestyle 
at baseline, and 2) whether there are differences in HF risk among hypertensive men and 
women by awareness, treatment and blood pressure control status at baseline. 
5.2 Methods 
Participants 
Five independent cross-sectional population-based health examination surveys (the 
National FINRISK Study) were carried out in five geographic areas of Finland in 1982, 1987, 
1992, 1997 and 2002.(Vartiainen et al.) The original random sample was stratified by area, 
gender and 10-year age group according to the World Health Organization (WHO) MONICA 
(MONItoring trends and determinants of CArdiovascular disease) protocol.(Pajak et al., 1988) 
The participation rate varied by year from 65% to 88%.(Vartiainen et al.) The subjects 
included in the five surveys were 25 to 64 years of age, and the 1997 and 2002 surveys also 
included subjects aged 65 to 74 years. Subjects who participated in more than one survey were 
included only in the first survey cohort. The total sample size of the five surveys was 38,737. 
The final sample comprised 18,346 men and 19,729 women after excluding the participants 
with a history of HF (n=457) at baseline, and the participants with incomplete data on any 
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variables required for this analysis (n=205). The participants provided informed consent 
(verbal from 1982 to 1992 and written in 1997 and 2002). These surveys were conducted 
according to the ethical rules of the National Public Health Institute, and the investigations 
were performed in accordance with the Declaration of Helsinki.  
Baseline measurements 
A self-administered questionnaire was mailed to the participants to be completed at home 
and returned to the survey site. The questionnaire included questions on medical history, 
socioeconomic factors, physical activity, smoking habits, dietary intake, and alcohol 
consumption. Education level, measured as the total number of school years, was divided into 
birth cohort-specific tertiles. Data on the history of myocardial infarction or diabetes mellitus 
at baseline were obtained from the questionnaire and collected by hospital discharge diagnosis 
or drug register. Data on the use of antihypertensive agents at baseline were obtained from the 
questionnaire and drug register. Data on the history of valvular heart disease at baseline were 
collected by hospital discharge register.(Hu et al., 2010b; Hu et al., 2003; Wang et al., 2010b, 
2011a; Wang et al., 2011b) A detailed description of the questions on lifestyle factors 
including physical activity, smoking, and vegetable consumption has been presented 
elsewhere.(Hu et al., 2003; Wang et al., 2010b, 2011a) Alcohol consumption was categorized 
into four groups: none, 0.1-35, 35.1-70, and >70 g per week.  
At the survey site, specially trained research nurses measured participants’ height and 
weight by using the standardized WHO MONICA protocol.(Pajak et al., 1988) Height and 
weight were measured without shoes and with light clothing. The measurements of height 
were rounded to the nearest centimeter and weight to nearest 100 grams.(Pajak et al., 1988) 
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BMI was calculated as weight in kilograms divided by the square of height in meters. Blood 
pressure was measured twice from the right arm after five minutes of sitting using a mercury 
sphygmomanometer, and the mean of these two blood pressures was used in the analyses. A 
person was considered to have hypertension when the average blood pressure was at least 
140 mmHg systolic and/or 90 mmHg diastolic or if he/she reported having taken 
antihypertensive drugs during the preceding 7 days.(Hu et al., 2005a) Awareness of 
hypertension was defined as a participant having reported a previous diagnosis of 
hypertension or current use of antihypertensive drug treatment. People on antihypertensive 
drug treatment, whose measured blood pressure level was < 140/90 mmHg, were considered 
to be adequately treated (controlled). The study population was classified into five groups 
according to their blood pressure status at baseline: normotensive participants, unaware and 
untreated hypertensive patients, hypertensive people aware of their hypertensive status but 
untreated, patients treated with antihypertensive drugs and adequately treated, patients 
treated with antihypertensive drugs but not controlled. After blood pressure measurement, a 
venous blood specimen was taken. Total cholesterol was determined by an enzymatic method 
(CHOD-PAP, Boehringer MANNHEIM, Mannheim, Germany). All samples were analyzed 
in the same central laboratory at the National Public Health Institute. 
In our previous publication, healthy lifestyle factors are defined as moderate or high level 
of physical activity, never smoking, BMI <25 kg/m
2, and vegetable consumption ≥3 
times/week.(Wang et al., 2011a) Since we found a graded inverse association between the 
number of healthy lifestyle factors and the risk of HF,(Wang et al., 2011a) a healthy lifestyle 
was defined as having two or more healthy lifestyle factors. 
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Prospective follow-up 
Follow-up information was from the Finnish Hospital Discharge Register and the 
National Social Insurance Institution’s Register on special reimbursement for HF drugs for 
non-fatal outcomes and the Finnish Causes of Death Register for fatal outcomes by record 
linkage using the personal identification numbers assigned to every citizen of Finland. The 
International Classification of Diseases (ICD) codes 427.00 and 427.10 (ICD-8), 428, 4029B 
(hypertensive heart disease with HF) and 4148A-X (ischemic HF with chronic coronary heart 
disease) (ICD-9), and I 50, I11.0 (hypertensive heart disease with HF), I13.0 and I13.2 
(hypertensive heart and renal disease with HF) (ICD-10) were used to identify HF cases in the 
above-mentioned national databases. A HF diagnosis was made by the treating physicians, 
based on a clinical assessment and examinations as considered relevant by the clinician in 
charge of treatment. Follow-up of each cohort member continued until the date of the 
diagnosis of HF from the Hospital Discharge Register, Causes of death register or from the 
National Social Insurance Institution’s Drug reimbursement Register or death resulting from 
causes other than HF, or December 31, 2007. The overall positive predictive value of HF 
diagnosis in this FINRISK study was 85.9% (negative predictive value 97.9%).(Mahonen et 
al., 2012) 
Statistical analyses 
Differences in the general characteristics of study subjects by blood pressure and lifestyle 
status were tested using General Linear Models after adjustment for age, sex and study year. 
Cox proportional hazards regression was used to calculate the hazard ratio (HR) and 95% 
confidence intervals (CIs) for the five different blood pressure groups and the two different 
83 
 
lifestyle groups. Next, participants were placed into 10 groups according to their blood 
pressure and lifestyle status at baseline.  Cox proportional hazards regression was used to 
estimate the association between the ten groups and HF risk. Different blood pressure and 
lifestyle categories were included in the Cox proportional hazards regression models as 
dummy and categorical variables, and the significance of the trend over different categories 
was tested in the same models by giving an ordinal numeric value for each dummy variable. 
The proportional hazards assumption in the Cox model was assessed with graphical methods, 
and with models including time-by-covariate interactions.(Cox, 1972) In general, all 
proportionality assumptions were appropriate.  
All the above analyses were first carried out adjusting for age, sex, study year, and further 
for education and alcohol consumption, and further for total cholesterol, and histories of 
myocardial infarction, valvular heart disease, and diabetes. To avoid a potential bias due to 
severe disease at baseline, additional analyses were carried out excluding the subjects who 
died during the first two years of follow-up (n=290). In order to determine if the definition of a 
healthy lifestyle used would influence the results, we did a sensitivity analysis whereby having 
three or four healthy lifestyle factors constituted a healthy lifestyle. Men and women were 
combined in the analyses because there was no significant gender difference. Statistical 
significance was considered to be P<0.05. All the above statistical analyses were performed 
with PASW for Windows, version 19.0 (SPSS Inc, Chicago, III). 
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5.3 Results 
During a median follow-up of 14.1 years (interquartile range 5.9-20.9 years), 638 men 
and 445 women developed HF. General characteristics of the study population at baseline are 
presented by blood pressure and lifestyle status in Table 13. 
After adjustment for age, sex, study year, education and alcohol consumption 
(multivariable model 2), the risk of HF was significantly higher in subjects in all 
hypertensive groups compared with normotensive group, while the risk of HF was 
significantly lower in the group with a healthy lifestyle compared with the group without a 
healthy lifestyle (Table 14). Compared with the HF risk in the normotensive group, the risk 
of HF increased 39% for the hypertensive, unaware, and untreated group, 51% for the 
hypertensive, aware, and untreated group, 60% for the hypertensive, treated, and 
uncontrolled group, 71% for the hypertensive, treated, and controlled one. The risk of HF 
increased 84% among the group without a healthy lifestyle compared with the group with a 
healthy lifestyle. Further adjustment for total cholesterol, and histories of myocardial 
infarction, valvular heart disease, and diabetes affected these results only slightly. 
Table 15 presents the HR of HF for subjects by different combinations of blood pressure 
and lifestyle status. The multivariable-adjusted (model 2) HRs of HF in the ten subgroups (1] 
normotensive group with a healthy lifestyle – reference group; 2] hypertensive, unaware, 
untreated group with a healthy lifestyle; 3] hypertensive, aware, untreated group with a 
healthy lifestyle; 4] hypertensive, treated, controlled group with a healthy lifestyle; 5] 
hypertensive, treated, uncontrolled group with a healthy lifestyle; 6] normotensive group 
without a healthy lifestyle; 7] hypertensive, unaware, untreated group without a healthy 
lifestyle; 8] hypertensive, aware, untreated group without a healthy lifestyle; 9] hypertensive,  
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Table 13. General characteristics of study subjects at baseline* 
 Healthy lifestyle factors ≥ 2                        Healthy lifestyle factors < 2 P value 
Normoten
sive 
Hypertensive 
unaware and 
untreated 
Hypertensive 
aware but 
untreated 
Hypertensive 
treated and 
controlled 
Hypertensive 
treated and 
uncontrolled 
Normoten
sive 
Hypertensive 
unaware and 
untreated 
Hypertensive 
Aware but 
untreated 
Hypertensive 
treated and 
control 
Hypertensive 
treated and 
uncontrolled 
  No. of subjects 14,859 5,797 3,815 553 2,238 4,359 3,075 1,853 269 1,257  
  Age at baseline (yrs) 41.1 49.1 48.9 54.0 56.3 42.9 51.2 50.3 55.4 57.7 <0.001 
  Body mass index (kg/m2) 24.8 26.0 27.0 27.9 28.4 27.3 28.2 29.4 30.2 30.2 <0.001 
  Diastolic blood pressure (mmHg) 76 86 92 80 91 76 87 93 78 92 <0.001 
  Systolic blood pressure (mmHg) 124 149 155 126 156 126 150 156 126 156 <0.001 
  Serum cholesterol (mmol/l) 5.59 5.89 5.89 5.62 5.77 5.83 6.05 6.08 5.75 5.87 <0.001 
  Education (yrs) 11.4 10.8 10.9 10.9 10.7 10.0 9.8 9.9 9.8 9.9 <0.001 
  Alcohol consumption (g/week) 43.6 50.0 53.2 45.6 49.8 55.4 68.9 75.2 53.0 61.7 <0.001 
  Low physical activity (%) 5.5 4.9 4.7 8.0 8.7 16.1 18.0 15.8 29.0 24.5 <0.001 
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Table 13 continued 
  Vegetable consumption ≥ 3 times/wk (%)   74.7 73.1 76.3 83.2 80.7 19.2 15.5 16.6 16.9 11.2 <0.001 
  Ever or current smoker (%) 39.1 37.0 37.5 41.7 37.4 74.1 67.8 64.7 65.5 59.6 <0.001 
  History of diabetes (%) 1.8 1.2 2.1 7.6 7.0 2.3 1.7 2.1 10.4 8.1 <0.001 
  History of myocardial infarction (%) 2.2 1.0 1.2 5.3 4.6 3.0 2.3 2.7 15.7 6.6 <0.001 
  History of valvular heart disease (%) 0.1 0.1 0.2 0.6 0.3 0.2 0.1 0.0 0.6 0.2 0.028 
*Values represent mean or percentage; adjusted for age, sex and study year. Healthy lifestyle factors are defined as moderate or high level of 
physical activity, never smoking, body mass index < 25 kg/m
2
, and vegetable consumption  ≥ 3 times/week. Normotensive was defined as systolic 
blood pressure < 140 mmHg, diastolic blood pressure < 90 mmHg and without antihypertensive drug treatment. 
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Table 14. Hazard ratios of heart failure by lifestyle factors and hypertensive status* 
 
No. of  subjects Case Person-yrs 
Model 1 Model 2 Model 3 
HR (95% CI) 
†
 HR (95% CI) ‡ HR (95% CI) § 
Lifestyle factors       
   Healthy lifestyle factors  ≥ 2        27,262 527 401,561 1.00 1.00 1.00 
   Healthy lifestyle factors < 2 10,813 556 152,284 1.88 (1.67-2.13) 1.84 (1.63-2.08) 1.79 (1.58-2.02) 
   P trend    <0.001 <0.001 <0.001 
Hypertensive status       
   Normotensive 19,218 248 26,449 1.00 1.00 1.00 
   Hypertensive, unaware, untreated 8,872 397 125,835 1.39 (1.19-1.64) 1.39 (1.18-1.63) 1.40 (1.19-1.65) 
   Hypertensive, aware, untreated 5,668 208 198,441 1.52 (1.26-1.83) 1.51 (1.25-1.82) 1.49 (1.24-1.80) 
   Hypertensive, treated, controlled 822 31 152,777 1.63 (1.12-2.37) 1.60 (1.10-2.33) 1.34 (0.92-1.95) 
   Hypertensive, treated, uncontrolled 3,495 199 50,343 1.72 (1.42-2.09) 1.71 (1.41-2.07) 1.53 (1.26-1.86) 
   P trend    <0.001 <0.001 <0.001 
*Normotensive was defined as systolic blood pressure < 140 mmHg, diastolic blood pressure < 90 mmHg and without antihypertensive drug 
treatment. 
†Adjusted for age, study year and sex. 
‡Adjusted for age, study year, sex, education, alcohol consumption and lifestyle factors/hypertensive status. 
§Adjusted for age, study year, sex, education, alcohol consumption, lifestyle factors/hypertensive status, total cholesterol, history of myocardial 
infarction, history of valvular heart disease and history of diabetes. 
CI = confidence interval; HR = hazard ratio.  
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Table 15. Hazard ratios of heart failure in normotensive individuals* and in different categories of hypertensive individuals by different levels of 
lifestyle factors 
 
No. of  subjects Case Person-yrs 
Model 1 Model 2 Model 3 
HR (95% CI) 
†
 HR (95% CI) ‡ HR (95% CI) § 
Healthy lifestyle factors ≥ 2                              
   Normotensive 14,859 135 220,224 1.00 1.00 1.00 
   Hypertensive, unaware, untreated 5,797 186 91,520 1.52 (1.21-1.90) 1.50 (1.20-1.88) 1.51 (1.21-1.89) 
   Hypertensive, aware, untreated 3,815 93 55,258 1.56 (1.19-2.03) 1.54 (1.18-2.01) 1.51 (1.16-1.97) 
   Hypertensive, treated, controlled 553 19 6,300 2.28 (1.41-3.70) 2.24 (1.39-3.64) 1.96 (1.21-3.18) 
   Hypertensive, treated, uncontrolled 2,238 94 28,259 1.93 (1.48-2.53) 1.91 (1.46-2.50) 1.69 (1.29-2.22) 
Healthy lifestyle factors < 2       
   Normotensive 4,359 113 61,093 2.18 (1.69-2.80) 2.12 (1.65-2.72) 2.03 (1.58-2.61) 
   Hypertensive, unaware, untreated 3,075 211 46,263 2.76 (2.21-3.45) 2.68 (2.14-3.35) 2.62 (2.09-3.28) 
   Hypertensive, aware, untreated 1,853 115 26,458 3.15 (2.45-4.05) 3.05 (2.37-3.93) 2.93 (2.27-3.77) 
   Hypertensive, treated, controlled 269 12 3,005 2.37 (1.31-4.29) 2.27 (1.25-4.11) 1.76 (0.97-3.19) 
   Hypertensive, treated, uncontrolled 1,257 105 15,465 3.32 (2.55-4.31) 3.21 (2.47-4.18) 2.80 (2.14-3.65) 
P trend    <0.001 <0.001 <0.001 
*Normotensive was defined as systolic blood pressure < 140 mmHg, diastolic blood pressure < 90 mmHg and without antihypertensive drug treatment. 
†Adjusted for age, study year and sex. 
‡Adjusted for age, study year, sex, education, and alcohol consumption. 
§Adjusted for age, study year, sex, education, alcohol consumption, total cholesterol, history of myocardial infarction, history of valvular heart disease 
and history of diabetes. 
CI = confidence interval; HR = hazard ratio. 
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Table 16. Hazard ratios of heart failure by different lifestyle factors and hypertensive* subgroups 
 No. of  
subjects 
Case Person-yrs 
Model 1 Model 2 Model 3 
HR (95% CI) 
†
 HR (95% CI) ‡ HR (95% CI) § 
Healthy lifestyle VS Medication       
   Hypertensive, untreated, healthy lifestyle factors ≥ 2 9,612 279 146,777 1.00 1.00 1.00 
   Hypertensive, treated, healthy lifestyle factors < 2
†
 1,526 117 18,469 2.17 (1.73-2.70) 2.10 (1.68-2.63) 1.75 (1.39-2.21) 
Healthy lifestyle + medication VS Non-healthy lifestyle + No medication       
   Hypertensive, treated, healthy lifestyle factors ≥ 2                                                           2,791 113 34,559 1.00 1.00 1.00 
   Hypertensive, untreated, healthy lifestyle factors < 2
†
                                                                             4,928 326 72,721 1.46 (1.17-1.82) 1.44 (1.16-1.80) 1.55 (1.24-1.95) 
*Normotensive was defined as systolic blood pressure < 140 mmHg, diastolic blood pressure < 90 mmHg and without antihypertensive drug 
treatment. 
†Adjusted for age, study year and sex. 
‡Adjusted for age, study year, sex, education, and alcohol consumption.  
§Adjusted for age, study year, sex, education, alcohol consumption, total cholesterol, history of myocardial infarction, history of valvular heart 
disease and history of diabetes. 
CI = confidence interval; HR = hazard ratio. 
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treated, controlled group without a healthy lifestyle; and 10] hypertensive, treated,  
uncontrolled group without a healthy lifestyle) were 1.00, 1.50 (95% CI 1.20-1.88), 
1.54(95% CI 1.18-2.01), 2.24 (95% CI 1.39-3.64), 1.91(95% CI 1.46-2.50), 2.12 (95% CI 
1.65-2.72), 2.68 (95% CI 2.14-3.35), 3.05 (95% CI 2.37-3.93), 2.27 (95% CI 1.25-4.11), and 
3.21 (95% CI 2.47-4.18) (Ptrend <0.001), respectively. Further adjustment for total cholesterol, 
and histories of myocardial infarction, valvular heart disease, and diabetes did not 
appreciably alter the results. 
Table 16 presents the comparison between the association of engaging in a healthy 
lifestyle with the risk of HF and the association of using antihypertensive drugs with the risk 
of HF. In the multivariable-adjusted analyses (model 2), hypertensive subjects who used 
antihypertensive drugs but did not engage in a healthy lifestyle had a significantly higher risk 
of HF (HR 2.10; 95% CI 1.68-2.63) than hypertensive subjects who did not use 
antihypertensive drug but engaged in a healthy lifestyle. Hypertensive subjects who did not 
use antihypertensive drugs and did not engage in a healthy lifestyle had a significant higher 
risk of HF (HR 1.44; 95% CI 1.16-1.80) compared with hypertensive subjects who used 
antihypertensive drug and engaged in a healthy lifestyle. Further adjustment for total 
cholesterol, and histories of myocardial infarction, valvular heart disease, and diabetes 
affected these results only slightly.  
5.4 Discussion 
The results of the present study suggest that the risk of HF was higher in untreated 
unaware, aware treated and controlled, and aware treated and uncontrolled hypertensive 
people than in normotensive people. Treated hypertensive subjects without a healthy lifestyle 
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had a higher risk of incident HF than untreated hypertensive subjects with a healthy lifestyle; 
however, treated hypertensive subjects with a healthy lifestyle had a lower risk of incident 
HF than untreated hypertensive subjects without a healthy lifestyle.  
High blood pressure has long been shown as an independent risk factor for HF risk. 
Levy et al.(Levy et al., 1996) showed that hypertensive subjects had an increased risk of HF. 
In 2003, Haider et al.(Haider et al., 2003) demonstrated that elevated blood pressure was an 
independent risk factor for incident HF. In addition to the evidence provided by 
observational studies, numerous clinical trials have shown that blood pressure reduction 
achieved with pharmacotherapy is associated with a decreased risk of HF in hypertensive 
subjects.(Dahlof et al., 2005; Julius et al., 2004; Liu et al., 2005; Wing et al., 2003) The 
current study supports the findings of the previous studies and adds additional information: 
despite antihypertensive drug treatment and adequate control of hypertension, the risk of HF 
remained relatively high. This stresses the importance of adequate primary prevention and 
more effective early management of hypertension.  
Modifiable lifestyle factors like smoking,(Djousse et al., 2009; Eriksson et al., 1989b; He 
et al., 2001; Hoffman et al., 1994; Wilhelmsen et al., 2001) physical activity,(Djousse et al., 
2009; Hu et al., 2010b; Kenchaiah et al., 2009; Wang et al., 2010b) adiposity,(Djousse et al., 
2009; Hu et al., 2010b; Kenchaiah et al., 2002; Kenchaiah et al., 2009; Levitan et al., 
2009a) ,and dietary intake,(Djousse et al., 2009; Wang et al., 2011b) have been shown to be 
independently associated with the risk of HF in various studies. Also, we found that there was 
a graded inverse association between the number of healthy lifestyle factors and the risk of HF 
in this Finnish population.(Wang et al., 2011a) In the current study, we assessed the joint 
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effects of hypertensive status (awareness, antihypertensive drug treatment, blood pressure 
control status) and lifestyle pattern on the risk of HF. We found that subjects engaged in a 
healthy lifestyle at baseline generally had lower risk of HF than those did not, and this 
association could be found in normotensive subjects as well as hypertensive subjects 
regardless of their awareness, and treatment. 
Numerous trials have investigated the effect of antihypertensive drug treatment on HF 
risk in hypertensive subjects.(Dahlof et al., 2005; Julius et al., 2004; Liu et al., 2005; Wing et 
al., 2003) However, no previous study had studied the differences in HF risk among 
hypertensive people by antihypertensive treatment and lifestyle status. In the current study, 
we first showed that the risk of incident HF was higher in the treated hypertensive subjects 
without a healthy lifestyle than in the untreated hypertensive subjects with a healthy lifestyle. 
Since one may argue that patients with treated hypertension might be more likely to have 
severe hypertension than hypertensive patients with a healthy lifestyle, it cannot be 
concluded that a healthy lifestyle may be more effective in preventing HF than 
antihypertensive treatment in hypertensive subjects. In order to understand this possible bias, 
we did additional analyses to compare the incident HF risk between the treated hypertensive 
subjects who engaged in a healthy lifestyle and the untreated hypertensive subjects who did 
not engage in a healthy lifestyle, and still found that a healthy lifestyle may be associated 
with a further reduced HF risk in hypertensive people. Our finding supports the statement of 
one recent review: “use a combination of lifestyle changes and pharmacotherapy to achieve 
systolic blood pressure goals and to achieve the ultimate goal of reducing end-organ 
damage”.(Baliga, 2007)  In 2010, the AHA published the AHA 2020 impact goals: “By 
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2020, to improve the cardiovascular health of all Americans by 20% while reducing deaths 
from cardiovascular diseases and stroke by 20%”.(Lloyd-Jones et al., 2010) In order to 
achieve this goal, a new concept–cardiovascular health was introduced by the 
AHA.(Lloyd-Jones et al., 2010) Seven metrics including not only health factor but also 
health behaviours were proposed to be monitored to determine the changing prevalence of 
cardiovascular health status.(Lloyd-Jones et al., 2010) Our results support the fundamental 
expansion of prevention efforts proposed by the AHA.  
There are several strengths and limitations in our study. First, a major strength of the study 
is the large number of both men and women from a homogeneous population who participated 
in the study. Second, the follow-up time was sufficiently long to ascertain a large number of 
HF endpoint events. Finally, we also carried out additional analyses excluding the subjects 
who died during the first two years of follow-up to avoid a potential bias due to a severe 
disease at baseline. A limitation of our study is that information on self-reported physical 
activity, smoking habits, vegetable consumption, alcohol consumption and antihypertensive 
drug treatment was recorded only once at baseline. We have no data on possible changes in 
these factors during the follow-up. However, the misclassification of the levels of these factors 
during the follow-up is most probably not systematically related to the outcome, but may 
weaken the observed association. In addition, we cannot completely either exclude the effects 
of residual confounding due to measurement error in the assessment of confounding factors, or 
some unmeasured dietary factors.  
In conclusion, the present study demonstrates that the risk of HF increased in hypertensive 
people despite antihypertensive drug treatment and adequate control of hypertension, which 
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emphasized the importance of adequate primary prevention efforts. In addition, our study also 
indicated that lifestyle intervention may be at least as effective in preventing HF as 
antihypertensive treatment in hypertensive subjects, which justifies the inclusion of ideal 
health behavioral factors into the definition of cardiovascular health of the AHA.(Lloyd-Jones 
et al., 2010) The results may also help encourage people at high HF risk to engage in health 
lifestyle changes while initiating medical therapy aiming at good blood pressure control. 
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CHAPTER 6. CONCLUSIONS  
It is generally believed that lifestyle interventions are beneficial in preventing and 
treating cardiovascular diseases. However, scientific evidence is lacking regarding the effect 
of engaging in healthy lifestyle in preventing heart failure (HF). In this dissertation: it is 
demonstrated that 1) moderate and high levels of occupational or leisure-time physical 
activity are associated with a reduced risk of HF; 2) coffee consumption is not detrimental to 
HF patients; 3) maintaining a BMI ≤25 kg/m2, consuming vegetable ≥3 times a week, 
abstaining from smoking and engaging in moderate or high level of physical activity were 
individually and jointly associated with a decreased risk of HF among both men and women; 
and 4) lifestyle intervention may be at least as effective in preventing HF as antihypertensive 
treatment in hypertensive subjects. These results justified the recommendations, such as 
increasing physical activity, eating healthy diet, stopping smoking and maintaining optimal 
body weight, made by health-care professionals to the general public. Also, the result of our 
studies may help to encourage people of high heart failure risk to attend lifestyle intervention 
programs targeting reducing heart failure risk factors or preventing heart failure, and to 
motivate health-care professionals to increase uptake to these programs.  
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